Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1050.Time spend outdoors in summer,48500,0.0132707004034178,0.0183714815116313,-0.0227374033593795,0.0492788041662151,0.470084143095829
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1060.Time spent outdoors in winter,44832,0.0215339827465058,0.0208694866588187,-0.0193702111047788,0.0624381765977904,0.302158715718855
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1070.Time spent watching television (TV),49636,0.0347620717086247,0.0182582300313354,-0.00102405915279277,0.0705482025700421,0.0569327107005867
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1080.Time spent using computer,44774,-0.0537196697807941,0.019770980672664,-0.0924707918992155,-0.0149685476623728,0.00659115179372837
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1090.Time spent driving,43653,-0.0174231532372119,0.0204589844029629,-0.0575227626670192,0.0226764561925953,0.394438787246519
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1160.Sleep duration,51426,0.00723991426141914,0.0171246010471995,-0.0263243037910919,0.0408041323139302,0.672460125795964
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34317,-0.0317381261321525,0.0207293861929494,-0.0723677230703334,0.00889147080602838,0.125782523832551
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34317,0.038570369757881,0.0205295424991108,-0.00166753354037621,0.0788082730561381,0.0603031587004122
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34317,0.0203073395250472,0.0240328363067152,-0.0267970196361147,0.0674116986862091,0.398139630228665
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34317,-5.94117583089114e-06,0.0249828380193528,-0.0489723036937624,0.0489604213421006,0.999810259383207
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34317,-6.51256665946128e-05,0.0258260010531246,-0.0506840877307189,0.0505538363975297,0.997988017330917
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34317,0.0126732387532852,0.0490982136259379,-0.0835592599535531,0.108905737460124,0.796319252918197
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34317,-0.0743232123044696,0.0517831097919237,-0.17581810749664,0.0271716828877008,0.151237505595664
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34317,0.0278253041366559,0.03574086811482,-0.0422267973683913,0.0978774056417032,0.43627480277272
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34317,0.0674651507626862,0.0265545482608988,0.0154182361713245,0.119512065354048,0.0110797837637121
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34317,0.0390504890175236,0.0186094365588817,0.00257599336211545,0.0755249846729317,0.0358916301803248
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34317,-0.00776084485168933,0.0263491918908908,-0.0594052609578352,0.0438835712544566,0.768352486736253
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34317,-0.0221654496225926,0.015167674994673,-0.0518940926121517,0.00756319336696652,0.143946428109449
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34317,0.000296232466714544,0.0194038969284524,-0.0377354055130521,0.0383278704464812,0.987819741567429
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34317,0.0099581108920293,0.0294530314837858,-0.0477698308161908,0.0676860526002494,0.73529357022393
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34317,-0.0110199579172203,0.0279240744250529,-0.0657511437903239,0.0437112279558834,0.693116605932741
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34317,0.0523240473846927,0.0345330318893731,-0.0153606951184785,0.120008789887864,0.129754939150341
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34317,0.0312087916748427,0.0323637440308775,-0.0322241466256773,0.0946417299753626,0.334911129688415
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34317,0.0126340886778456,0.0217708186204948,-0.0300367158183242,0.0553048931740154,0.561709884820626
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34317,0.0116131864789365,0.0206787822572687,-0.0289172267453101,0.0521435997031831,0.574401197070979
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34317,0.0340683594380765,0.0253889463277257,-0.0156939753642659,0.0838306942404189,0.179671194396081
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120040.Fatigue severity over the past week,34325,0.0500451951422108,0.0288153018375828,-0.00643279645945141,0.106523186743873,0.0824593928364278
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120041.Waking unrefreshed severity over the past week,34327,0.033124059153619,0.0283392982850273,-0.0224209654850345,0.0886690837922725,0.242495382565958
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120042.Cognitive symptoms severity over the past week,34325,0.0477595686930868,0.0312973536676696,-0.0135832444955456,0.109102381881719,0.127041626008665
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120098.Mobility problems today,34330,0.00386741868001461,0.0353021484516535,-0.0653247922852262,0.0730596296452554,0.91276683140554
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120099.Self-care problems today,34330,0.113109172284953,0.0557564841095279,0.0038264634302784,0.222391881139628,0.0425214460765994
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120100.Problems doing usual activities,34330,0.0293515132883465,0.0331611803208,-0.0356444001404216,0.0943474267171146,0.376114045149239
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120101.Pain or discomfort today,34330,-0.0213641748879245,0.0286104987590228,-0.0774407524556091,0.0347124026797601,0.455246343535358
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120102.Anxiety or depression today,34330,0.0262292731186648,0.0341850566846066,-0.040773437983164,0.0932319842204937,0.442936487531607
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120103.Scale to indicate how health is today,34295,-0.00364724048932884,0.00656636071523748,-0.0165173074911943,0.00922282651253662,0.578603449543193
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34315,0.0401698436981883,0.0342775718217646,-0.0270141970724703,0.107353884468847,0.24126441669566
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34299,0.011822905981532,0.0349196923308174,-0.0566196909868701,0.0802655029499341,0.734937351652517
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34319,0.0305056715653191,0.0283221247420844,-0.0250056929291663,0.0860170360598046,0.281461843933949
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34320,0.0556481761318184,0.0289693947676024,-0.00113183761268231,0.112428189876319,0.054767703201967
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34316,0.0326876729485726,0.0357543599589683,-0.0373908725710054,0.102766218468151,0.360617611185757
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120109.Feeling bad about self over the last two weeks,34293,0.0324505717087508,0.0362335785895896,-0.0385672423268448,0.103468385744346,0.37049036470513
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120110.Trouble concentrating over the last two weeks,34322,0.031867922044136,0.0365294838074668,-0.0397298662184989,0.103465710306771,0.383016191095975
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34305,0.0458315931181465,0.0552077989522081,-0.0623756928281814,0.154038879064474,0.406464368504562
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34253,0.0201119000225076,0.072015806242751,-0.121039080213284,0.1612628802583,0.78004269715094
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31350,0.0834753946989841,0.0387504780001855,0.00752445781862043,0.159426331579348,0.0312580863188759
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48397,0.0331770481511937,0.0409856103079533,-0.0471547480523948,0.113508844354782,0.418246723167937
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47131,0.0106533586560079,0.0246333866726473,-0.0376280792223807,0.0589347965343965,0.665399200855666
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1289.Cooked vegetable intake,50414,-0.0268835030602965,0.0176280287938188,-0.0614344394961814,0.00766743337558836,0.127260266414071
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49881,-0.0119144836138515,0.0188399110534653,-0.0488407092786436,0.0250117420509405,0.527126795837469
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1309.Fresh fruit intake,50397,-0.0353686486579671,0.0187661682612764,-0.0721503384500689,0.00141304113413473,0.0594809016106966
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1319.Dried fruit intake,48874,-0.0187701674009148,0.0197483013254186,-0.0574768379987351,0.0199365031969056,0.341882688306995
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X134.Number of self-reported cancers,51650,0.0218552264033213,0.0390845088564389,-0.054750410955299,0.0984608637619416,0.576044247804355
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X135.Number of self-reported non-cancer illnesses,51650,0.0955132835364099,0.0171947297267932,0.0618116132718952,0.129214953800925,2.80472480117645e-08
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X136.Number of operations, self-reported",51650,0.0236963549456087,0.0171296573765623,-0.00987777351245328,0.0572704834036708,0.166567909967099
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X137.Number of treatments or medications taken,51650,0.0761273069380434,0.0171192824125252,0.042573513409494,0.109681100466593,8.74660048406189e-06
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1438.Bread intake,50788,0.0130174216617341,0.00415653537282837,0.00487061233099046,0.0211642309924777,0.00173926447352648
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1458.Cereal intake,50032,0.0492893878092407,0.0177171586304046,0.0145637568936477,0.0840150187248337,0.00540613356575184
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1488.Tea intake,50583,0.00690981259271819,0.00393389623074646,-0.000800624019544877,0.0146202492049813,0.0790178259269456
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1498.Coffee intake,49334,-0.0917239528262008,0.0178828458743237,-0.126774330739875,-0.0566735749125263,2.93171453548189e-07
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1528.Water intake,49660,-0.0418033231798906,0.0182845609581391,-0.0776410626578432,-0.00596558370193801,0.0222469178817927
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1568.Average weekly red wine intake,42721,-0.0893265409084684,0.0208844174120805,-0.130259999036146,-0.0483930827807906,1.90201970815592e-05
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42712,-0.0688232427596711,0.0213688512326857,-0.110706191175735,-0.0269402943436072,0.00128082570516694
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1588.Average weekly beer plus cider intake,42761,0.0145628597313568,0.0233957174938943,-0.0312927465566759,0.0604184660193896,0.533648031410301
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1598.Average weekly spirits intake,42684,0.0103335372499966,0.0234357289096722,-0.035600491412961,0.0562675659129541,0.659268080323641
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1608.Average weekly fortified wine intake,42750,-0.0191019138735134,0.0425198825577813,-0.102440883686765,0.0642370559397379,0.653258908534464
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1737.Childhood sunburn occasions,45227,-0.0323189153787031,0.020677893634064,-0.0728475869014686,0.00820975614406245,0.118074598424838
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1807.Father's age at death,40432,0.0084370014271246,0.00551903661474663,-0.0023803103377788,0.019254313192028,0.12635566436492
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1845.Mother's age,39711,-0.00758852948307257,0.0084762589216018,-0.0242019969694121,0.00902493800326695,0.37065705115986
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1873.Number of full brothers,51157,0.0196970704368968,0.0172381516429169,-0.0140897067832204,0.053483847657014,0.253196454072153
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1883.Number of full sisters,51158,0.0204554503351425,0.017206628777216,-0.0132695420682009,0.054180442738486,0.234523915005449
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20015.Sitting height,51426,0.014954724764899,0.00527044749877078,0.00462464766730824,0.0252848018624897,0.00455061248820234
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20016.Fluid intelligence score,32603,-0.0198526604204167,0.0284258654128454,-0.0755673566295937,0.0358620357887603,0.484944884920282
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20018.Prospective memory result,32925,0.0292821021311021,0.0410242350706674,-0.0511253986074059,0.10968960286961,0.475384266025951
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32515,0.0036876663639816,0.00751555128875696,-0.011042814161982,0.0184181468899452,0.62367128984828
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32509,0.0236014584384828,0.00747927766850956,0.00894207420820401,0.0382608426687615,0.00160728727946752
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20023.Mean time to correctly identify matches,51343,0.00769714514743098,0.00418109337173101,-0.000497797861161798,0.0158920881560238,0.065641014793888
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#1.Illnesses of father_Heart disease,48452,-0.00974923795101279,0.00907102888736289,-0.0275284545702441,0.00802997866821848,0.282489827949706
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48033,0.000507386518974223,0.020559223963532,-0.0397886924495485,0.0408034654874969,0.980310998561565
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47997,0.0212698664125056,0.0277902967245724,-0.0331991151676563,0.0757388479926674,0.444058585239644
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#12.Illnesses of father_Severe depression,48029,-0.0496977825599457,0.0211284513829597,-0.0911095472705467,-0.00828601784934476,0.0186720454028432
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48031,0.00529306884249861,0.0154669006039222,-0.0250220563411888,0.035608194026186,0.732188985950723
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#2.Illnesses of father_Stroke,48189,-0.00018295333919884,0.0119116419878503,-0.0235297716353855,0.0231638649569878,0.987745736023718
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48126,-0.00761866638700684,0.0154726585558191,-0.0379450771564123,0.0227077443823986,0.62244428299707
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48031,0.000454766166243233,0.018698504069981,-0.0361943018109195,0.037103834143406,0.980596769725842
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48152,0.0344763911810603,0.0147738124522214,0.0055197187747064,0.0634330635874143,0.0196240011467219
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48300,0.00848281033293979,0.00935256423417912,-0.00984821556605128,0.0268138362319309,0.364413784759161
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#9.Illnesses of father_Diabetes,48156,0.0116318846842582,0.0128045567547002,-0.0134650465549542,0.0367288159234706,0.363666642278056
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49484,-0.00269628793954602,0.0108668278722851,-0.0239952705692249,0.0186026946901329,0.804042794604019
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49354,-0.00450952628465775,0.017557163776628,-0.0389215672868486,0.0299025147175331,0.797298016033312
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49302,0.0104292914269166,0.0366941628032015,-0.0614912676673583,0.0823498505211915,0.776242505395449
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49350,0.0146286824708933,0.0158158494587184,-0.0163703824681947,0.0456277474099814,0.355006839082478
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#2.Illnesses of mother_Stroke,49433,0.0192184460265672,0.0128521364345882,-0.00597174138522567,0.04440863343836,0.134835384575826
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49356,0.0118236784977015,0.0210565445976859,-0.0294471489137628,0.0530945059091658,0.574447790332888
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49332,0.000128250543578692,0.0199649360826264,-0.0390030241783691,0.0392595252655265,0.994874643219403
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49367,0.000724585189096164,0.015083126075565,-0.0288383419190112,0.0302875122972035,0.96168517272974
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49365,0.0203795926172515,0.0177743620390619,-0.0144581569793098,0.0552173422138129,0.251569152713074
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49580,0.00889385009242791,0.00852111270865896,-0.00780753081654364,0.0255952310013995,0.296614208988741
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49420,0.029082724485025,0.0132320591054775,0.00314788863828916,0.0550175603317608,0.0279652658571225
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46671,-0.00546290024177883,0.0173875533883602,-0.0395425048829648,0.0286167043994071,0.753383766782134
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46555,0.0816252861419607,0.102244905939425,-0.118774729499312,0.282025301783233,0.424686740336253
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46554,0.104217469981809,0.0832376448465241,-0.0589283139173783,0.267363253880996,0.210565526110743
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46641,-0.00719646932761932,0.0159393172532982,-0.0384375311440838,0.0240445924888452,0.651639508939326
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46560,0.0570777895144265,0.0538255853996516,-0.0484203578688905,0.162575936897744,0.288964323926547
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46574,0.0182364701117776,0.0299339005045901,-0.0404339748772189,0.0769069151007741,0.54238163569922
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46562,-0.0251539856866019,0.0403451090184523,-0.104230399362769,0.0539224279895647,0.532981639381001
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46570,0.0191533055685836,0.0360319191860756,-0.0514692560361245,0.0897758671732917,0.595032540220288
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46575,0.00192417708221952,0.0242012138346692,-0.0455102020337321,0.0493585561981712,0.936629697204885
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46577,0.0584507318120715,0.031708479724959,-0.00369788844884818,0.120599352072991,0.0652867752325811
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46757,0.00870123875657414,0.0112271750654677,-0.0133040243717426,0.0307065018848909,0.43833829039781
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46649,0.0388769882406135,0.0164294147505955,0.00667533532944629,0.0710786411517806,0.0179750046122002
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20127.Neuroticism score,46160,0.0288402064047311,0.0178353987974941,-0.00611717523835733,0.0637975880478196,0.105887995969888
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32603,0.034823112883506,0.0289911207445831,-0.021999483775877,0.0916457095428889,0.229719871759885
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20161.Pack years of smoking,31551,0.0179211016907507,0.00866678454490094,0.000934203982744873,0.0349079993987566,0.0386930143364492
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31551,0.0160805746988855,0.00810338376397066,0.000197942521503028,0.031963206876268,0.0472437229592865
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20191.Fluid intelligence score,31270,0.0130853893336801,0.0320260197241994,-0.0496856093257507,0.0758563879931109,0.68285519411296
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31270,-0.00887729015675339,0.0326251828330526,-0.0728226485095366,0.0550680681960298,0.785553243450816
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20240.Maximum digits remembered correctly,30631,0.00126933692472738,0.0339332949813677,-0.0652399212387533,0.067778595088208,0.970161732667971
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20255.Spirometry QC measure,44642,0.0392909933028162,0.0230769837437551,-0.00593989483494377,0.0845218814405762,0.0886569227413677
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20261.avMSE,29823,0.00510471223972283,0.00941357781413354,-0.0133459002759789,0.0235553247554246,0.587651948869174
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20262.Myopia diagnosis,29823,-0.0315425658061291,0.0411444538868702,-0.112185695424395,0.0491005638121364,0.443331986530527
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20280.Glucose-lactate,39547,0.0293700191903888,0.00539193367789052,0.0188018291817234,0.0399382091990542,5.19892623184308e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20281.Spectrometer-corrected alanine,39583,0.0196676710613512,0.00531615989165363,0.00924799767371007,0.0300873444489923,0.00021667450240792
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32526,-0.0473033187840175,0.0252042520813924,-0.0967036528635466,0.0020970152955115,0.0605791999775487
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32523,-0.0365821884871745,0.0509460120255188,-0.136436372057191,0.0632719950828423,0.47274092549878
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32520,-0.134435091173086,0.0559517108136952,-0.244100444367928,-0.0247697379782429,0.01629550961733
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32520,-0.0418137211136733,0.0243916612507725,-0.0896213771651875,0.00599393493784087,0.0865162264773325
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32520,-0.0590215328968772,0.0395072090376817,-0.136455662610733,0.018412596816979,0.135226855241913
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32527,-0.047576059464147,0.0508643711370965,-0.147270226892856,0.0521181079645621,0.349633307037997
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32527,-0.0492362950507873,0.0336248464317859,-0.115140994057088,0.016668403955513,0.143152876185451
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32527,-0.00732304119770844,0.036593223062337,-0.079045758399889,0.0643996760044721,0.841391311811217
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32527,0.0828419256138748,0.0567398457639945,-0.0283681720835544,0.194052023311304,0.144317838911749
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32527,0.0168513256424187,0.0657774740048777,-0.112072523407142,0.145775174691979,0.797812621410579
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32527,0.0351210931122427,0.037459380217656,-0.0382992921143631,0.108541478338848,0.348487415100583
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32527,0.0234772152297701,0.0645034387494896,-0.10294952471923,0.14990395517877,0.715890463544392
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32527,-0.0406770844383339,0.0492718741404575,-0.137249957753631,0.0558957888769627,0.409074198922918
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32530,-0.116529873512187,0.0653979860716367,-0.244709926212595,0.0116501791882208,0.074807509150583
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32530,-0.0657648195212888,0.0326065295833648,-0.129673617504684,-0.00185602153789388,0.0437344425947949
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32530,-0.0767287060362621,0.045186547771397,-0.1652943396682,0.011836927595676,0.089535510071012
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32530,0.0328535119435111,0.0752014725656262,-0.114541374285116,0.180248398172138,0.662214150406579
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20600.Liking for adding salt to foods,35202,0.0107767006930521,0.0250937566330419,-0.03840706230771,0.0599604636938143,0.66759851819776
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20601.Liking for aniseed,35202,0.0443477189449056,0.0249863576050615,-0.00462554196101494,0.0933209798508262,0.0759449850981817
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20602.Liking for apple juice,35202,-0.000997507250510805,0.0252073676089336,-0.0504039477640207,0.0484089332629991,0.968435006651265
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20603.Liking for apples,35202,-0.0268403833676724,0.0253912572015283,-0.076607247482668,0.0229264807473231,0.290501326359643
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20604.Liking for asparagus,35202,-0.0479600850272073,0.0256545904951467,-0.0982430823976948,0.00232291234328024,0.0615854009346908
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20605.Liking for aubergine,35202,-0.0731169393340257,0.0249365151926239,-0.121992509111568,-0.0242413695564829,0.00337326256513351
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20606.Liking for avocados,35202,-0.0543157030832365,0.025662566600812,-0.104614333620828,-0.00401707254564485,0.0343211256002888
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20607.Liking for bacon,35202,-0.00905144949774014,0.0253899717293766,-0.0588157940873183,0.040712895091838,0.721475012990549
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20608.Liking for baked or steamed fish,35202,-0.0504260413435909,0.025535838474023,-0.100476284752676,-0.000375797934505727,0.048324565333443
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20609.Liking for bananas,35202,0.0102804202092221,0.0260685108397653,-0.0408138610367179,0.061374701455162,0.693321494603824
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35202,-0.0564188286935901,0.025222145408493,-0.105854233694236,-0.0069834236929438,0.0253137709112563
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20611.Liking for beef steak,35202,-0.0713884872264793,0.0254300710148514,-0.121231426415588,-0.0215455480373706,0.00500522782527844
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20612.Liking for beetroot,35202,-0.00825919231684327,0.0257370940923154,-0.0587038967377815,0.042185512104095,0.748287414491083
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20613.Liking for bell pepper,35202,-0.0561174687767571,0.025499390906972,-0.106096274954422,-0.00613866259909196,0.0277746997505197
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20614.Liking for bicycling,35202,-0.0312692027194857,0.0252232026069692,-0.0807066798291454,0.018168274390174,0.215112069185123
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20615.Liking for biscuits,35202,0.0260194308765477,0.0251529541451336,-0.0232803592479142,0.0753192210010096,0.300948703008167
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20616.Liking for bitter foods,35202,-0.0537537318909459,0.024876704279557,-0.102512072278878,-0.00499539150301422,0.0307312126808898
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20617.Liking for bitter or ale,35202,-0.0556420599862972,0.0256251707704401,-0.10586739469636,-0.00541672527623456,0.029922910533016
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20618.Liking for black olives,35202,-0.0634438738299948,0.0254109312469611,-0.113249299074039,-0.013638448585951,0.0125490214576253
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20619.Liking for black pepper,35202,0.00428403936912201,0.0253153290714753,-0.0453340056109695,0.0539020843492135,0.865621045770353
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20620.Liking for blue cheese,35202,-0.0643581456921995,0.0253816654359865,-0.114106209946733,-0.014610081437666,0.0112383103759727
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20621.Liking for bolognese sauce,35202,-0.0514744262642575,0.0256327669576655,-0.101714649501282,-0.0012342030272332,0.0446510999232253
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20622.Liking for broad beans,35202,-0.0645741057299699,0.0251724599002531,-0.113912127134466,-0.0152360843254738,0.0103223645235307
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20623.Liking for broccoli,35202,-0.0108569768709106,0.0262191518767795,-0.0622465145493985,0.0405325608075773,0.678819153201495
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20624.Liking for brown rice,35202,-0.0286951680692934,0.0255541788257014,-0.0787813585676682,0.0213910224290813,0.261497427895205
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20625.Liking for brussel sprouts,35202,-0.0394053547319972,0.0255330055215461,-0.0894500455542276,0.0106393360902332,0.122783385477603
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20626.Liking for burgers (meat),35202,-0.0629443198758523,0.025118067427101,-0.11217573203297,-0.0137129077187343,0.0122266053692039
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20627.Liking for burn of spicy foods,35202,-0.0318859109975827,0.025000963520297,-0.0808877994973648,0.0171159775021995,0.202198339324519
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20628.Liking for butter on bread,35202,0.000167032428976532,0.0256165256189892,-0.0500413577842423,0.0503754226421954,0.994797549289855
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20629.Liking for butternut squash,35202,-0.00973088151944287,0.025462793025272,-0.0596379558489761,0.0401761928100903,0.702349257074879
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20630.Liking for cabbage,35202,-0.0413098943586975,0.0253559967691927,-0.0910076480263152,0.00838785930892015,0.103299277766497
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20631.Liking for cake,35202,0.0310704569080755,0.0252193902459091,-0.0183595479739063,0.0805004617900573,0.217972154473192
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20632.Liking for cake icing,35202,-0.00527390572445595,0.0249024198972989,-0.0540826487231618,0.0435348372742499,0.832280248751155
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20633.Liking for capers,35202,-0.0638829718510916,0.0250385043817098,-0.112958440439243,-0.0148075032629403,0.0107424572092173
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20634.Liking for cauliflower,35202,-0.0124328903436738,0.0256045597760229,-0.0626178275046787,0.0377520468173311,0.627279124440706
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20635.Liking for cereal or granola bar,35202,0.0130209805616664,0.025171890677377,-0.0363159251659924,0.0623578862893253,0.604969007878373
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20636.Liking for cheesecake,35202,-0.0223671610642413,0.0251262965376421,-0.0716147022780199,0.0268803801495373,0.3733831296454
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20637.Liking for cherries,35202,-0.029175741346099,0.0263116541163627,-0.0807465834141699,0.0223951007219719,0.267517382374228
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20638.Liking for chicken,35202,-0.0460897661779067,0.026400860521465,-0.0978354527999782,0.00565592044416476,0.080878445504634
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20639.Liking for chilli pepper,35202,-0.0439051371873986,0.0250034513277209,-0.0929119017897315,0.00510162741493432,0.0791217240929367
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20640.Liking for chips or french fries,35202,-0.018443838164243,0.0253765084343539,-0.0681817946955767,0.0312941183670907,0.467358863350243
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20641.Liking for cigarette smoking,35202,0.040623924776524,0.0398579592439695,-0.0374976753416562,0.118745524894704,0.308121534270753
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20642.Liking for cod,35202,-0.0620958808071534,0.0258254115708798,-0.112713687486078,-0.011478074128229,0.0162128149123415
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20643.Liking for coffee with sugar,35202,0.026745293457077,0.0275004938611801,-0.027155674510836,0.0806462614249899,0.33080339800634
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20644.Liking for coffee without sugar,35202,-0.0816146207931495,0.0256103514206907,-0.131810909577703,-0.0314183320085956,0.00144255252290193
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20645.Liking for coriander,35202,-0.0471748932685902,0.0253151000284249,-0.0967924893243029,0.00244270278712257,0.0624166618850122
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20646.Liking for corn flakes,35202,0.0663540366809916,0.0252258707700007,0.0169113299717903,0.115796743390193,0.00854007111129856
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20647.Liking for cream,35202,-0.0247772081889404,0.0252091799997262,-0.0741872009884038,0.024632784610523,0.325695111603445
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20648.Liking for croissant,35202,0.0202532181547319,0.0252472909663091,-0.0292314721392339,0.0697379084486978,0.422457731573039
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20649.Liking for cucumber,35202,0.0155711044446977,0.025464808363312,-0.0343399199473938,0.0654821288367892,0.540897149747409
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20650.Liking for curry,35202,-0.0319169297182574,0.0254134817486313,-0.0817273539455747,0.0178934945090599,0.209176150205664
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20651.Liking for dairy products,35202,0.0187873069335746,0.025543031996709,-0.031277035779975,0.0688516496471242,0.462040562978254
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20652.Liking for dark chocolate,35202,-0.0174028947562071,0.0253357152757438,-0.0670608966966648,0.0322551071842507,0.49216497700502
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20653.Liking for diet fizzy drinks,35202,-0.00936607592350861,0.0254217993267957,-0.0591928026040281,0.0404606507570109,0.712561788793211
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20654.Liking for dried fruit,35202,-0.0304674475842632,0.0251329771844952,-0.0797280828658739,0.0187931876973475,0.225442029351508
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20655.Liking for eggs,35202,-0.0471427603203514,0.0259484402393174,-0.0980017031894136,0.00371618254871076,0.0692763052298247
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20656.Liking for exercising alone,35202,-0.0044750872559647,0.0250660410396432,-0.0536045276936654,0.044654353181736,0.858308483391333
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20657.Liking for exercising with others,35202,-0.0287698388065342,0.0249797448179301,-0.0777301386496772,0.0201904610366087,0.249457697081982
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20658.Liking for extra virgin olive oil,35202,-0.0132325344189613,0.0254985374841389,-0.0632096678878735,0.0367445990499508,0.603803871768631
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20659.Liking for fatty foods,35202,-0.00142612147869712,0.0251706597961216,-0.0507606146790954,0.0479083717217011,0.95481855944016
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20660.Liking for fresh tomatoes,35202,-0.0112154716580267,0.027108994810793,-0.064349101487181,0.0419181581711276,0.67908867317888
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20661.Liking for fried chicken,35202,0.0178170238693678,0.0253686244647884,-0.0319054800816174,0.0675395278203531,0.482490814746139
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20662.Liking for fried or battered fish,35202,-0.0505203278013166,0.0253255309262258,-0.100158368416719,-0.000882287185913939,0.04608447412538
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20663.Liking for fruit,35202,-0.00220601571010863,0.0274996049521269,-0.0561052414162773,0.0516932099960601,0.936063775342362
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20664.Liking for garlic,35202,-0.0438636187216884,0.0256728801120851,-0.0941824637413751,0.00645522629799843,0.087560135055086
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20665.Liking for gherkins,35202,-0.0299165969876663,0.0252538975287342,-0.0794142361439854,0.0195810421686528,0.236187479131648
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20666.Liking for globe artichoke,35202,-0.0228105879771715,0.0251613159639314,-0.072126767266477,0.0265055913121341,0.364651535164464
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20667.Liking for goat's cheese,35202,-0.0774875531314679,0.0250127176372672,-0.126512479700512,-0.0284626265624241,0.00195356492899167
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20668.Liking for going to a cafe,35202,0.0384009559746998,0.0254968311855304,-0.0115728331489397,0.0883747450983393,0.132067577997369
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20669.Liking for going to the gym,35202,-0.0244060030294633,0.0249086094429789,-0.0732268775377019,0.0244148714787754,0.327194915733804
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20670.Liking for going to the pub,35202,-0.0358927144141186,0.0250485466609619,-0.084987865869604,0.0132024370413668,0.151906562511304
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20671.Liking for grapefruit,35202,-0.0522933009872269,0.0250541220162977,-0.10139938013917,-0.00318722183528342,0.0368911273268468
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20672.Liking for green olives,35202,-0.0574800961271226,0.0255609995017456,-0.107579655150544,-0.00738053710370123,0.0245480368212491
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20673.Liking for haddock,35202,-0.0531499444223022,0.0256892095872834,-0.103500795213378,-0.0027990936312268,0.0385724692093557
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20674.Liking for ham,35202,-0.034160781873092,0.0252775035414181,-0.0837046888142716,0.0153831250680875,0.176584637282103
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20675.Liking for hard cheese,35202,-0.0344066552598601,0.0258187020663778,-0.0850113113099605,0.0161980007902403,0.182681594504162
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20676.Liking for herring,35202,-0.0377684144331879,0.0249074309295746,-0.0865869790551542,0.0110501501887784,0.129458445638568
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20677.Liking for honey,35202,-0.0135153453874626,0.0251581263706664,-0.0628252730739688,0.0357945822990436,0.591129039624057
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20678.Liking for horseradish or wasabi,35202,-0.0346869765622608,0.0250559593577516,-0.0837966569034539,0.0144227037789322,0.166269294570064
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20679.Liking for ice cream,35202,0.00824841148756866,0.0254794978399164,-0.0416914042786676,0.0581882272538049,0.746150401407422
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20680.Liking for jam,35202,0.0299879004551502,0.0252447821473942,-0.0194918725537425,0.0794676734640429,0.234903576695691
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20681.Liking for kiwi fruit,35202,-0.00671355742082219,0.0252563842931165,-0.0562160706353306,0.0427889557936862,0.790385561071856
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20682.Liking for lager,35202,-0.0133945073589592,0.0253154166203917,-0.0630127239349269,0.0362237092170084,0.59674314441261
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20683.Liking for lamb,35202,-0.0455757682767275,0.0255862469492342,-0.0957248122972266,0.00457327574377158,0.0748966960580659
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20684.Liking for lemons,35202,-0.0239602506246219,0.0252767855590244,-0.0735027503203098,0.025582249071066,0.343192809850099
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20685.Liking for lentils or beans,35202,-0.0318774869052668,0.025541886426733,-0.0819395843016635,0.01818461049113,0.212039455696613
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20686.Liking for liver,35202,-0.0709933893700553,0.0254689125031631,-0.120912457876255,-0.0210743208638555,0.00532126560402992
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20687.Liking for mackerel,35202,-0.0526879220515799,0.0252324203961181,-0.102143466027971,-0.00323237807518856,0.0368107082833739
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20688.Liking for marzipan,35202,-0.00515406113225567,0.0250347815852851,-0.0542222330394145,0.0439141107749032,0.836891457340759
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20689.Liking for mayonnaise,35202,-0.0614094077620783,0.0253101355992197,-0.111017273536549,-0.0118015419876076,0.0152701066052033
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20690.Liking for melon,35202,0.00762311508943226,0.0261019734304197,-0.0435367528341904,0.0587829830130549,0.770252752309508
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20691.Liking for milk chocolate,35202,-0.00279023064061458,0.0254300797276877,-0.0526331869068825,0.0470527256256533,0.912632062170743
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20692.Liking for mushrooms,35202,-0.0432110712880846,0.0260837396528492,-0.094335201007669,0.0079130584314998,0.0976222515649033
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20694.Liking for orange juice,35202,0.021099176612762,0.0254367768228376,-0.0287569059599997,0.0709552591855237,0.406853011154519
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20695.Liking for oranges,35202,0.00809007606216504,0.0255709775813548,-0.0420290399972904,0.0582091921216205,0.75172199478175
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20696.Liking for pasta,35202,-0.0313921425789114,0.0255790734245299,-0.08152712649099,0.0187428413331672,0.219750833443624
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20697.Liking for pears,35202,-2.14693599282472e-05,0.0257573152782176,-0.0505058073052348,0.0504628685853783,0.999334958213921
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20698.Liking for pizza,35202,-0.00174792816232279,0.0253235759068026,-0.0513821369396559,0.0478862806150103,0.944971932885308
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20699.Liking for plain yogurt,35202,-0.0422824861497152,0.0253019417726099,-0.0918742920240306,0.00730931972460031,0.0947263275938863
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20700.Liking for plums,35202,-0.0143838055389918,0.0255695246639947,-0.0645000738804213,0.0357324628024378,0.573761279536755
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20701.Liking for pollock,35202,-0.0680074403177393,0.0250167653746356,-0.117040300452025,-0.0189745801834535,0.00656834768598529
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20702.Liking for pork chop,35202,-0.0175500371563841,0.0250947592415417,-0.0667357652698057,0.0316356909570376,0.484347249541072
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20703.Liking for porridge,35202,0.00523255516024056,0.0255462447834605,-0.0448380846153421,0.0553031949358232,0.837711138467713
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20704.Liking for potato crisps,35202,0.0116519065226223,0.0254428247860716,-0.0382160300580779,0.0615198431033226,0.646986839559464
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20705.Liking for potatoes,35202,0.00192688392086293,0.025520850437962,-0.0480939829375425,0.0519477507792684,0.939816368538481
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20706.Liking for prawns,35202,-0.0802853134504277,0.0256772504836355,-0.130612724398353,-0.0299579025025021,0.00177221461129577
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20707.Liking for raw carrots,35202,-0.033482217211436,0.0254334769154308,-0.0833318319656805,0.0163673975428084,0.188045498018497
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20708.Liking for red meat,35202,-0.0466537559733862,0.0252783891813646,-0.0961993987688608,0.00289188682208838,0.0649765983289894
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20709.Liking for red wine,35202,-0.051470175261564,0.0253313171371137,-0.101119556850307,-0.00182079367282116,0.0421891693938507
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35202,-0.0111323882596707,0.0259519122896483,-0.0619981363473813,0.0397333598280399,0.66795891871449
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20711.Liking for roast chicken,35202,-0.0171436117663109,0.0264707876251025,-0.0690263555115118,0.03473913197889,0.517229206565185
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20712.Liking for salad dressing,35202,-0.0079957478907523,0.0251731081367229,-0.0573350398387292,0.0413435440572246,0.75077105833888
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20713.Liking for salad leaves,35202,-0.00717880185741275,0.025902478149229,-0.0579476590299016,0.0435900553150761,0.781672059083387
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20714.Liking for salami,35202,-0.0106146975154374,0.0250529935792857,-0.0597185649308373,0.0384891698999625,0.671800105158972
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20715.Liking for salmon,35202,-0.0706175322914868,0.026224894902601,-0.122018326300585,-0.0192167382823888,0.00709659611854701
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20716.Liking for salty foods,35202,0.00199827553071384,0.0250639934648854,-0.0471271516604616,0.0511237027218893,0.936455839443535
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20717.Liking for salty pretzels,35202,-0.00971291965034667,0.0251803141496162,-0.0590663353835945,0.0396404960829011,0.699700438742702
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20718.Liking for sardines,35202,-0.0553027542606591,0.0250861519482697,-0.104471612079268,-0.00613389644205046,0.0275082896500076
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20719.Liking for sausages (meat),35202,-0.0441003515241822,0.025100181798964,-0.0932967078501516,0.00509600480178712,0.0789493457004103
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20720.Liking for savoury biscuits,35202,0.0285371606651964,0.0253136662854375,-0.021077625254261,0.0781519465846539,0.259621753851717
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35202,-0.0709708286014175,0.0250618248641977,-0.120092005335245,-0.0218496518675899,0.00463640246518213
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20722.Liking for skimmed milk,35202,-0.00205895135646329,0.0250817536083963,-0.0512191884289201,0.0471012857159935,0.934576905424487
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20723.Liking for smoked fish,35202,-0.0858283425921496,0.0253339581639976,-0.135482900593585,-0.0361737845907142,0.000706754752719305
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20724.Liking for soft cheese,35202,-0.0334784394929496,0.0253092414621143,-0.0830845527586936,0.0161276737727945,0.185936803495746
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20725.Liking for soy sauce,35202,-0.0135166874518016,0.0255782803676355,-0.0636501169723672,0.0366167420687639,0.597201589328357
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20726.Liking for soya milk,35202,-0.00224485080224795,0.0252689920381033,-0.0517720751969303,0.0472823735924344,0.929212098626301
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20727.Liking for spicy foods,35202,-0.0232618221008151,0.0251594575784584,-0.0725743589545936,0.0260507147529635,0.35520636427156
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20728.Liking for spinach,35202,-0.0442404292631467,0.0254314562073184,-0.0940860834294907,0.00560522490319732,0.0819573396891034
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20729.Liking for spirits,35202,-0.0440474947027823,0.0248327457862481,-0.0927196764438286,0.00462468703826405,0.0761286139810314
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20730.Liking for strawberries,35202,-0.00253707158988937,0.0275499241900539,-0.0565349230023951,0.0514607798226163,0.926628187998129
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35202,-0.00701288962154687,0.0258448843545263,-0.0576688629564184,0.0436430837133247,0.786130359413989
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20732.Liking for sweet foods,35202,0.0358470387341384,0.0252157888952336,-0.0135759075005194,0.0852699849687962,0.155166774517297
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20733.Liking for taking the stairs,35202,-0.0248861367326484,0.0260679443676424,-0.0759793076932274,0.0262070342279307,0.339767834079361
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20734.Liking for tea with sugar,35202,0.0451428159618292,0.0305193891385545,-0.0146751867497376,0.104960818673396,0.139127484660375
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20735.Liking for tea without sugar,35202,0.0154597390919874,0.0264725542204883,-0.0364264671801696,0.0673459453641444,0.559237845906983
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20736.Liking for tomato ketchup,35202,-0.0341931278129655,0.0252136220176357,-0.0836118269675314,0.0152255713416004,0.175082574027268
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20737.Liking for tinned tuna,35202,-0.0407020995190308,0.0254599823130249,-0.0906036648525597,0.00919946581449808,0.109921914772618
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20738.Liking for turnip (white),35202,-0.0172145038223117,0.0251169292090869,-0.0664436850721219,0.0320146774274986,0.493121623542152
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20739.Liking for vegetables,35202,-0.0466618837758659,0.0277851913482856,-0.101120858818506,0.00779709126677384,0.0931056497311139
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20740.Liking for vinegar,35202,-0.00303823067601653,0.025395844726812,-0.0528140863405681,0.046737624988535,0.90477445108599
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20741.Liking for watching television,35202,0.0419475477290736,0.0253645090220457,-0.00776688995413593,0.0916619854122832,0.0981980730943047
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20742.Liking for whisky,35202,-0.0300812318911729,0.026367510322121,-0.0817615521225301,0.0215990883401842,0.253958702100593
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20743.Liking for white bread,35202,-0.0198261023460278,0.0249475236168743,-0.0687232486351015,0.029071043943046,0.426797553164877
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20744.Liking for white rice,35202,-0.0507250146851446,0.0254915065073447,-0.10068836743954,-0.000761661930749016,0.046628249703906
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20745.Liking for white wine,35202,-0.0183591297165871,0.0251032857482449,-0.067561569783147,0.0308433103499729,0.464584369251684
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35202,-0.0217845999279359,0.0253050936942568,-0.0713825835686792,0.0278133837128074,0.389323419704813
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20747.Liking for whole milk,35202,0.0502389888147605,0.0252224565494936,0.000802973977753078,0.0996750036517679,0.0464130469091273
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20748.Liking for wholemeal bread,35202,-0.0146060182873275,0.0261378457338833,-0.0658361959257388,0.0366241593510838,0.576304299460865
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20749.Liking for working up a sweat,35202,-0.0459969676080507,0.0254038477966565,-0.0957885092894974,0.00379457407339614,0.0702246234020179
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21001.Body mass index (BMI),51522,-0.121129166002881,0.016608479725015,-0.153681786263911,-0.0885765457418519,3.10775317364367e-13
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21002.Weight,51543,-0.00369154115172965,0.00967827665204389,-0.0226609633897357,0.0152778810862764,0.702890497230362
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21021.Pulse wave Arterial Stiffness index,32843,0.0108907162820436,0.0077867540209055,-0.00437132159893119,0.0261527541630184,0.161961242471165
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34578,-0.00137275357857956,0.0272596292056359,-0.054801626821626,0.0520561196644669,0.9598376588421
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34578,-0.0145401985203653,0.0282101587238685,-0.0698321096191474,0.0407517125784169,0.606267258131361
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34578,-0.0183261000658427,0.0279310642998986,-0.0730709860936439,0.0364187859619585,0.511761693013662
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21040.Satisfaction with bowel habits,34549,0.0485223445853938,0.0260481475605596,-0.00253202463330292,0.0995767138040906,0.0625186257730332
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34547,0.0480807254330049,0.0275665505768548,-0.00594971369763045,0.10211116456364,0.0811583834643676
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21042.Greatest number of times bowels opened per day,34536,0.066725462125716,0.0278921417334585,0.0120568643281374,0.121394059923295,0.0167618251135402
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21043.Least number of times bowels opened per week,34480,-0.00535400197260456,0.0277665445717948,-0.0597764293333223,0.0490684253881132,0.847102023672846
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21044.Average number of times bowels opened per day,34510,0.10178835069037,0.0313250132873054,0.0403913246472512,0.163185376733488,0.00115996722845844
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34583,0.0137825179769168,0.0283601847951808,-0.0418034442216376,0.0693684801754712,0.626990393354222
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34579,0.0113147071686547,0.0283116423582754,-0.0441761118535651,0.0668055261908744,0.689423346483976
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30111,-0.0387666251960867,0.0419095980137831,-0.120909437303102,0.0433761869109282,0.354998553997736
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34580,0.0573007217338911,0.0297564952109659,-0.00102200887960204,0.115623452347384,0.0541739801064838
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34578,0.0244794748073279,0.0426278062055945,-0.0590710253556373,0.108029974970293,0.565803436178457
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34581,-0.0122234892860989,0.0337205788459676,-0.0783158238241954,0.0538688452519976,0.716990456160568
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34579,0.0185051884303872,0.083388339851695,-0.144935957678935,0.181946334539709,0.824383674583136
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34581,0.00136051440918225,0.0318517351363256,-0.0610688864580159,0.0637899152763804,0.965930330031744
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34581,-0.0667467577144277,0.0334796855143038,-0.132366941322463,-0.00112657410639225,0.0462156685297827
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34338,0.0567820722939084,0.0295405189982641,-0.00111734494268922,0.114681489530506,0.0546107234036176
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34581,0.00354493032532362,0.0294309981047714,-0.0541398259600283,0.0612296866106755,0.904129841541939
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34582,-0.0465619901407979,0.0407806982702207,-0.12649215875043,0.0333681784688347,0.253577049543161
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34580,-0.0433068937425338,0.0282847548613021,-0.0987450132706859,0.0121312257856184,0.125773267675591
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34578,-0.0713072078415392,0.0281893939799558,-0.126558420042252,-0.0160559956408259,0.0114342632265496
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X21100.Water hardness (USGS classification),51283,0.0118833213735054,0.0175240789300994,-0.0224638733294894,0.0462305160765001,0.497705204982117
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2139.Age first had sexual intercourse,48627,-0.00598547321327835,0.00444083001957916,-0.0146895000516535,0.00271855362509681,0.17772617044819
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2149.Lifetime number of sexual partners,46651,-0.00218796810373933,0.0196728696869566,-0.0407467926901742,0.0363708564826956,0.911444825134833
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22032.IPAQ activity group,46614,-0.0324441665632597,0.0188717135823282,-0.069432725184623,0.00454439205810359,0.0855923666413061
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22033.Summed days activity,47185,-0.0111745144528884,0.00430868517195716,-0.0196195373899244,-0.00272949151585235,0.00950677675616
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22034.Summed minutes activity,46614,-0.00527610023903431,0.00440507620580855,-0.0139100496024191,0.00335784912435045,0.231033887439051
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22037.MET minutes per week for walking,45857,0.00156452700222912,0.00432172252931028,-0.00690604915521904,0.0100351031596773,0.717344537219654
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22038.MET minutes per week for moderate activity,46614,-0.00729873070780411,0.00451101243011757,-0.0161403150708345,0.00154285365522632,0.105680634031287
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22039.MET minutes per week for vigorous activity,46614,-0.0771002717549557,0.0189342796900844,-0.114211459947521,-0.0399890835623902,4.67700399011719e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22040.Summed MET minutes per week for all activity,45857,-0.00487191642973684,0.00445524322765651,-0.0136041931559436,0.00386036029646991,0.274175670326414
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X2217.Age started wearing glasses or contact lenses,46008,0.00104761397152078,0.00516473397860737,-0.00907526462654966,0.0111704925695912,0.839262056743279
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X22501.Year ended full time education,31269,-0.0314908667501347,0.0213081243821029,-0.0732547905390564,0.0102730570387869,0.139482207813269
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X22506.Tobacco smoking,31220,-0.0817167664689617,0.0691117425606996,-0.217175781887933,0.0537422489500094,0.23709072711894
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49628,0.021840791190635,0.0381518612775087,-0.0529368569132819,0.096618439294552,0.567008684972955
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23098.Weight,51177,-0.0019546686230891,0.00973073323134476,-0.0210269057565248,0.0171175685103466,0.840797202343714
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23099.Body fat percentage,51156,-0.00323091950835747,0.00940508642391313,-0.0216648888992272,0.0152030498825123,0.73120320777205
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23100.Whole body fat mass,51120,-0.00251315424266956,0.00895362622839612,-0.020062261650326,0.0150359531649868,0.778953659496757
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23101.Whole body fat-free mass,51172,0.00205363794065613,0.00829211224024273,-0.0141989020502196,0.0183061779315319,0.804398092311552
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23102.Whole body water mass,51177,0.00164762612502716,0.00829206637823394,-0.0146048239763114,0.0179000762263657,0.842499606936025
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23104.Body mass index (BMI),51177,-0.117675652518095,0.0167081032842266,-0.150423534955179,-0.084927770081011,1.92557133395962e-12
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23105.Basal metabolic rate,51175,0.00204666194905908,0.00889129839819341,-0.0153802829114,0.0194736068095182,0.817948130562931
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23106.Impedance of whole body,51174,0.0116919468146046,0.00681807225102169,-0.0016714747973979,0.0250553684266071,0.0863847306248388
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23107.Impedance of leg (right),51174,0.0015523327263594,0.00561806502055138,-0.00945907471392131,0.0125637401666401,0.782311358281762
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23108.Impedance of leg (left),51173,0.00315256598720598,0.00557982879960319,-0.00778389846001627,0.0140890304344282,0.572082949490651
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23109.Impedance of arm (right),51168,0.0153248142076874,0.00684157276911163,0.00191533158022865,0.0287342968351462,0.0251018652588024
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23110.Impedance of arm (left),51172,0.0162753439779711,0.00683569345302032,0.00287738481005131,0.029673303145891,0.0172755573883291
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23111.Leg fat percentage (right),51173,-0.019118263376397,0.0116337040845355,-0.0419203233820865,0.00368379662929254,0.1003217687332
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23112.Leg fat mass (right),51172,-0.00216438249629026,0.0120755124123325,-0.0258323868244619,0.0215036218318814,0.857752689727014
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23113.Leg fat-free mass (right),51172,0.0124881954446301,0.00893239093925485,-0.00501929079630936,0.0299956816855697,0.162100454602149
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23114.Leg predicted mass (right),51171,0.0116917089892192,0.00896762551348218,-0.00588483701720588,0.0292682549956443,0.192323464524645
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23115.Leg fat percentage (left),51170,-0.0214183532771779,0.012041489373993,-0.0450196724502042,0.00218296589584848,0.0752979533457364
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23116.Leg fat mass (left),51170,-0.00672582057407869,0.0125544666520986,-0.0313325752121919,0.0178809340640345,0.592148640131419
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23117.Leg fat-free mass (left),51168,0.0120289013076081,0.00926580066529141,-0.00613206799636311,0.0301898706115792,0.194228140291499
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23118.Leg predicted mass (left),51167,0.0115765130953514,0.00930373496802921,-0.00665880744198583,0.0298118336326887,0.213404767257608
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23119.Arm fat percentage (right),51167,-0.0194567795457621,0.0103524070965246,-0.0397474974549503,0.000833938363426202,0.0601943991590786
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23120.Arm fat mass (right),51164,-0.0325237223972845,0.0101365894899495,-0.0523914377975856,-0.0126560069969834,0.00133561560550442
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23121.Arm fat-free mass (right),51164,0.00247638908615299,0.008302354242332,-0.0137962252288177,0.0187490034011237,0.765495151020115
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23122.Arm predicted mass (right),51163,0.00142283248595554,0.00830488679705739,-0.0148547456362769,0.017700410608188,0.863969706049646
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23123.Arm fat percentage (left),51160,-0.0153996381501902,0.010597026407747,-0.0361698099093744,0.00537053360899396,0.146178695088093
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23124.Arm fat mass (left),51159,-0.0269770242063376,0.0101007504450215,-0.0467744950785797,-0.00717955333409555,0.00757169079013928
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23125.Arm fat-free mass (left),51155,-0.00240857459874771,0.00844053428088357,-0.0189520217892795,0.0141348725917841,0.775371990681981
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23126.Arm predicted mass (left),51154,-0.00378748987792581,0.0084782737136433,-0.0204049063566667,0.0128299266008151,0.65507435809885
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23127.Trunk fat percentage,51152,-0.00221924967513531,0.00675111061458182,-0.0154514264797157,0.0110129271294451,0.742367104264421
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23128.Trunk fat mass,51148,0.00186799490333517,0.00736840055828815,-0.0125740701909096,0.0163100599975799,0.799872722751771
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23129.Trunk fat-free mass,51142,-0.00208070617991235,0.00754621014364573,-0.016871278061458,0.0127098657016333,0.782758592960534
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23130.Trunk predicted mass,51140,-0.00244831671169162,0.00753362653349048,-0.017214224717333,0.0123175912939497,0.745194806649665
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23400.Total Cholesterol,39587,-0.0546900091262611,0.00567343670134661,-0.0658099450609005,-0.0435700731916218,6.25151340039292e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39587,-0.0462064300350271,0.00551347125963724,-0.0570128337039161,-0.0354000263661381,5.70465180918195e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39587,-0.0351981731686089,0.00554100927957351,-0.046058551356573,-0.0243377949806448,2.17942595031121e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23403.VLDL Cholesterol,39587,-0.0202212242507827,0.00546833396158007,-0.0309391588154796,-0.00950328968608571,0.000218149957901004
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23404.Clinical LDL Cholesterol,39587,-0.0539854340140366,0.00550657934908461,-0.0647783295382424,-0.0431925384898308,1.25878400574777e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23405.LDL Cholesterol,39587,-0.0539230387337802,0.00546033888486677,-0.064625302948119,-0.0432207745194413,6.20576550403086e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23406.HDL Cholesterol,39587,-0.0422417256014732,0.00624079705123511,-0.0544736878218941,-0.0300097633810524,1.34591796313406e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23407.Total Triglycerides,39587,0.000696508355127067,0.00561130412306989,-0.0103016477260899,0.0116946644363441,0.901217152317745
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23408.Triglycerides in VLDL,39587,-0.000942850736634195,0.00570414612315125,-0.0121229771380106,0.0102372756647423,0.868716139647535
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23409.Triglycerides in LDL,39587,-0.00380203232254498,0.00535545420740763,-0.0142987225690639,0.00669465792397397,0.47775405132648
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23410.Triglycerides in HDL,39587,0.012830172671507,0.00529702825008698,0.00244799730133647,0.0232123480416774,0.0154404028290075
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39587,-0.0421540897482782,0.00562522841877177,-0.0531795374490709,-0.0311286420474856,7.04868851281037e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23412.Phospholipids in VLDL,39587,-0.0119005653529712,0.00552959110425195,-0.022738563917305,-0.0010625667886374,0.0313999173236485
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23413.Phospholipids in LDL,39587,-0.0523558408224064,0.00546682831575822,-0.0630708243212925,-0.0416408573235203,1.14465168784999e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23414.Phospholipids in HDL,39587,-0.0241940657294244,0.00587251775148216,-0.0357042005223294,-0.0126839309365193,3.81010631117821e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23415.Total Esterified Cholesterol,39587,-0.0571157092356296,0.00569293751232515,-0.0682738667597869,-0.0459575517114723,1.28893383415506e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39587,-0.0223578032098501,0.00546693077416988,-0.0330729875272231,-0.0116426188924771,4.34185008800517e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39587,-0.0521183040034093,0.00544049221281256,-0.0627816687405219,-0.0414549392662967,1.11530012794538e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39587,-0.044539066738225,0.00622727638399279,-0.0567445284508508,-0.0323336050255991,8.91251653991307e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23419.Total Free Cholesterol,39587,-0.0475135736875364,0.0056212229266031,-0.0585311706236784,-0.0364959767513943,3.09763972174107e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23420.Free Cholesterol in VLDL,39587,-0.0170976591062796,0.00550155482331457,-0.0278807065599761,-0.006314611652583,0.00188830011403338
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23421.Free Cholesterol in LDL,39587,-0.0570727596007583,0.00552614704538264,-0.0679040078097082,-0.0462415113918083,6.33981771417574e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23422.Free Cholesterol in HDL,39587,-0.0313903122862758,0.00619490151682222,-0.0435323192592474,-0.0192483053133043,4.08456816355171e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39587,-0.0397076892237028,0.00548282347691227,-0.0504540232384508,-0.0289613552089548,4.619240865794e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23424.Total Lipids in VLDL,39587,-0.00849156143493327,0.00558260003598784,-0.0194334575054694,0.0024503346356029,0.128260757911022
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23425.Total Lipids in LDL,39587,-0.0517350259876769,0.00545532776535406,-0.0624274684077708,-0.0410425835675829,2.80572511612682e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23426.Total Lipids in HDL,39587,-0.0302028869563516,0.00599768646780809,-0.0419583524332554,-0.0184474214794477,4.81232900617093e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39587,-0.0553961226053567,0.00563712051448133,-0.0664448788137401,-0.0443473663969733,1.00132600654726e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23428.Concentration of VLDL Particles,39587,-0.0165974420952047,0.0054564093268681,-0.0272920043758662,-0.00590287981454327,0.00235536029267456
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23429.Concentration of LDL Particles,39587,-0.0413238165749862,0.00547370761828967,-0.052052283506834,-0.0305953496431384,4.60817196337351e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23430.Concentration of HDL Particles,39587,-0.0511653531202521,0.00564059061708932,-0.0622209107297472,-0.040109795510757,1.31716744933371e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39587,-0.00185951493066931,0.00599880647047577,-0.0136171756128018,0.0098981457514632,0.756579651369499
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23432.Average Diameter for LDL Particles,39587,-0.0248536794347906,0.00547773781291941,-0.0355900455481127,-0.0141173133214686,5.74235873783306e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23433.Average Diameter for HDL Particles,39587,0.00954270207837393,0.00635340046960515,-0.00290996284205216,0.0219953669988,0.13312147133069
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23434.Phosphoglycerides,39575,-0.0346814821778927,0.00556816204688202,-0.0455950797897815,-0.023767884566004,4.82800507846245e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39575,0.0196829085334042,0.00601153686345669,0.00790029628102908,0.0314655207857793,0.00106194756470251
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23436.Total Cholines,39575,-0.0401343557154164,0.00565912561914582,-0.0512262419289422,-0.0290424695018906,1.3785073789231e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23437.Phosphatidylcholines,39575,-0.0373989297991833,0.00564870545487805,-0.0484703924907443,-0.0263274671076224,3.68845419221399e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23438.Sphingomyelins,39574,-0.0494135075749381,0.00583441915086846,-0.0608489691106403,-0.0379780460392359,2.6844595557144e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23439.Apolipoprotein B,39587,-0.038455300489093,0.00549254299138163,-0.049220684752201,-0.027689916225985,2.63734847123634e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23440.Apolipoprotein A1,39587,-0.0359055232004539,0.00582573171617422,-0.0473239573641554,-0.0244870890367524,7.2998251285896e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39587,-0.014345827149617,0.00550612137333547,-0.0251378250413545,-0.00355382925787947,0.00918447864376249
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23442.Total Fatty Acids,39575,-0.0201794185702362,0.00535147566235288,-0.0306683108684479,-0.00969052627202455,0.000163312094102765
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23443.Degree of Unsaturation,39575,-0.0387687797501334,0.00593125605214387,-0.0503940416123354,-0.0271435178879315,6.4978473195288e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23444.Omega-3 Fatty Acids,39575,-0.029132311323602,0.00543915797120547,-0.0397930609471647,-0.0184715617000393,8.62660422363815e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23445.Omega-6 Fatty Acids,39575,-0.0357490683413201,0.00542299643748748,-0.0463781413587955,-0.0251199953238446,4.47386079535928e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39575,-0.0378387348019322,0.00542508968766713,-0.0484719105897598,-0.0272055590141046,3.18596324305053e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39575,-0.00421668977886324,0.00544620284975722,-0.0148912473643874,0.00645786780666091,0.438798171488428
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23448.Saturated Fatty Acids,39575,-0.017965857385523,0.00538441100657749,-0.0285193029584148,-0.00741241181263108,0.000849934021106156
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23449.Linoleic Acid,39575,-0.0279775080941602,0.0054650614884765,-0.0386890286115741,-0.0172659875767463,3.10226043529137e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23450.Docosahexaenoic Acid,39575,-0.040121070864014,0.00568228150953639,-0.0512583426227053,-0.0289837991053227,1.72563159385751e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39575,-0.0241506854009719,0.00550543957003888,-0.0349413469582481,-0.0133600238436957,1.15834836196263e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39575,-0.0123227550898491,0.00561249134857079,-0.0233232381330479,-0.00132227204665037,0.0281355464948012
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39575,-0.0219432470984939,0.00583598839951339,-0.0333817843615401,-0.0105047098354476,0.000170537189565195
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39575,0.0329199509848588,0.00594830309358624,0.0212612769214298,0.0445786250482878,3.17392636003576e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39575,0.00106748518757313,0.0053774272196157,-0.00947227216287365,0.0116072425380199,0.842646867651916
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39575,-0.0114640945441959,0.00574731181535458,-0.0227288257022909,-0.000199363386100951,0.0460941492524096
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39575,-0.0269990221130149,0.00575749063497608,-0.038283703757568,-0.0157143404684618,2.76347479396037e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39575,-0.0293030502854403,0.00595036922017509,-0.0409657739569834,-0.0176403266138971,8.54018161292304e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39573,0.018118503866749,0.00546233164763761,0.00741233383737933,0.0288246738961188,0.000911990453157289
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23460.Alanine,39583,0.0167314091480086,0.0052963251319843,0.00635061188931936,0.0271122064066978,0.00158578560771357
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23461.Glutamine,39543,0.0046204211045477,0.00524950224746905,-0.00566860330049163,0.014909445509587,0.37878414423432
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23462.Glycine,39569,0.0228680234857561,0.00550579233512912,0.012076670508903,0.0336593764626092,3.29233047568303e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23463.Histidine,39569,-0.00295458683675273,0.00524096752528262,-0.0132268831863067,0.00731770951280121,0.572933449123334
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39576,0.0136399110252611,0.00560179477345433,0.00266039326929059,0.0246194287812316,0.0149062127471668
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23465.Isoleucine,39585,0.0131380173232102,0.00546393641021608,0.00242870195918667,0.0238473326872337,0.0162062382371825
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23466.Leucine,39586,0.00780534943742095,0.00564341275480272,-0.00325573956199237,0.0188664384368343,0.166656815447213
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23467.Valine,39576,0.0152007039105246,0.00557253171555346,0.00427854174803978,0.0261228660730093,0.00638307290679048
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23468.Phenylalanine,39583,0.0343837452224889,0.00528757601409299,0.0240200962348667,0.0447473942101112,8.12470522122491e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23469.Tyrosine,39570,0.0438829108218758,0.00539559971954905,0.0333075353715596,0.0544582862721919,4.49501303279723e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23470.Glucose,39559,0.0210534284637896,0.00540426760842894,0.0104610639512689,0.0316457929763103,9.83198344411039e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23471.Lactate,39558,0.0143176112458787,0.00531471450011491,0.00390077082565346,0.0247344516661039,0.00706843834799652
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23472.Pyruvate,39539,0.00839347909862221,0.00525313528087795,-0.00190266605189857,0.018689624249143,0.110106817527706
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23473.Citrate,39586,0.0159535049598175,0.00535616140139555,0.00545542861308218,0.0264515813065527,0.00290073528601521
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23474.3-Hydroxybutyrate,39337,-0.00783609022836716,0.00521077848689834,-0.0180492160626879,0.00237703560595358,0.132647268217638
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23475.Acetate,39573,-0.0126440759975931,0.00529673123196781,-0.02302566921225,-0.00226248278293622,0.0169914532343315
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23476.Acetoacetate,39587,-0.0160393068893895,0.00518930053924158,-0.026210335946303,-0.00586827783247602,0.00199938646181284
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23477.Acetone,39587,-0.0174452582754082,0.00523221353471559,-0.0277003968034508,-0.00719011974736565,0.000857420829272791
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23478.Creatinine,39167,0.0178922064394516,0.00657087521335257,0.0050132910212806,0.0307711218576227,0.00647739093855328
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23479.Albumin,39586,-0.049214234915149,0.00537422414363776,-0.059747714236679,-0.038680755593619,5.95524988083542e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23480.Glycoprotein Acetyls,39587,0.0286474533569734,0.00563509803293535,0.0176026612124201,0.0396922455015267,3.74295031303903e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39587,0.0136443539248837,0.00567210865963232,0.00252702095200435,0.024761686897763,0.0161610710620681
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39587,0.0146913153093077,0.00569956194702174,0.00352017389314505,0.0258624567254703,0.00995729843680683
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39587,0.0146671717933295,0.00570319616754178,0.00348890730494757,0.0258454362817113,0.0101278089551383
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39587,0.0138412523890609,0.00565766893324707,0.00275222127989661,0.0249302834982251,0.0144376124574887
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39587,0.0156360076221739,0.00568230204046536,0.00449869562286184,0.0267733196214861,0.00593541522540887
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39587,0.0104938367092712,0.00560804944769427,-0.000497940208209575,0.021485613626752,0.0613345681080971
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39587,0.0146485152574102,0.00568918215005039,0.00349771824331144,0.025799312271509,0.0100388167445776
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39587,5.41439088773647e-05,0.00577531667111836,-0.0112654767665146,0.0113737645842694,0.992520017196726
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39587,0.00109244752446957,0.00578455679422598,-0.0102452837922134,0.0124301788411525,0.850208216102553
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39587,0.000880473701367527,0.00574529498081198,-0.010380304461024,0.012141251863759,0.878202100684414
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39587,-0.00535455769982635,0.00565873991389634,-0.0164456879310632,0.00573657253141049,0.344037874722394
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39587,-0.00998213003114105,0.005606887895816,-0.0209716303069404,0.00100737024465832,0.0750407073815247
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39587,-0.000431281320002952,0.00570023749534221,-0.0116037468108737,0.0107411841708678,0.939690373885203
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39587,0.00241458328801129,0.00583756414318805,-0.00902704243263728,0.0138562090086599,0.679151789123367
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39587,-0.00537590286124491,0.00571380965861768,-0.0165749697921356,0.00582316406964574,0.346790350019611
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23496.Total Lipids in Large VLDL,39587,-0.0074716997519688,0.00572118093400978,-0.018685214382628,0.00374181487869037,0.191581320802529
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23497.Phospholipids in Large VLDL,39587,-0.00401935260455494,0.00574938927978045,-0.0152881555929246,0.00724945038381474,0.48450481591495
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23498.Cholesterol in Large VLDL,39587,-0.0118838899378755,0.00561960580376706,-0.0228983173132589,-0.00086946256249202,0.0344695499207384
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39587,-0.0157895668570262,0.00552762653565943,-0.0266237148669187,-0.00495541884713373,0.00428925403067857
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39587,-0.00834978002237626,0.00572301664661462,-0.0195668926497409,0.00286733260498839,0.144589949145306
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23501.Triglycerides in Large VLDL,39587,-0.00781990213825286,0.00575520904284091,-0.019100111862221,0.00346030758571533,0.174244655994788
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39587,-0.0303923709997302,0.00545939887696089,-0.0410927927985736,-0.0196919492008869,2.63428503724035e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39587,-0.0256481934369897,0.00548212099053111,-0.0363931505784307,-0.0149032362955488,2.91364164442883e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39587,-0.0298505463567867,0.00545777281276295,-0.0405477810698021,-0.0191533116437713,4.58545239298575e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39587,-0.0390038396872719,0.00550579058217271,-0.0497951892283305,-0.0282124901462134,1.45833944465445e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39587,-0.0416501945118493,0.00556808450745291,-0.052563640146457,-0.0307367488772416,7.81449544135121e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39587,-0.0336633780931851,0.00545395818357899,-0.0443531361329999,-0.0229736200533703,6.89614329463325e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39587,-0.01373207139885,0.00562558016047426,-0.0247582085133795,-0.00270593428432043,0.0146573891124521
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39587,-0.014832464918394,0.00548406789935746,-0.0255812380011346,-0.00408369183565337,0.00684507135431947
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23510.Total Lipids in Small VLDL,39587,-0.0176794727789012,0.0054695610058643,-0.0283998123503952,-0.00695913320740718,0.00123034425799946
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23511.Phospholipids in Small VLDL,39587,-0.0284548042293614,0.0054320734195763,-0.0391016681317309,-0.0178079403269918,1.64156809743621e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23512.Cholesterol in Small VLDL,39587,-0.0271507269018038,0.0054428539334715,-0.0378187206114079,-0.0164827331921997,6.15545898637005e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39587,-0.0224623462360346,0.00545358621025056,-0.0331513752081257,-0.0117733172639435,3.82762690169222e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39587,-0.0350263658619507,0.00544165354138614,-0.0456920068030676,-0.0243607249208339,1.25622626543356e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23515.Triglycerides in Small VLDL,39587,-0.000691438867341231,0.00553954413586446,-0.0115489453736356,0.0101660676389531,0.900668653752664
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39587,-0.0130104722220459,0.00547178283741853,-0.0237351665833862,-0.00228577786070557,0.0174310243672019
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39587,-0.0115188425405056,0.00545651689198676,-0.0222136156487997,-0.000824069432211583,0.0347859175881938
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39587,-0.0061671033518862,0.00542480866909158,-0.0167997283433057,0.00446552163953331,0.255625284462655
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39587,-0.0227745876281394,0.00565669216083744,-0.0338617042633808,-0.011687470992898,5.69678411395864e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39587,-0.0261059405658903,0.00573019153852219,-0.0373371159813938,-0.0148747651503868,5.25643515997411e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39587,-0.0148293875958121,0.00549691777130653,-0.0256033464275729,-0.00405542876405136,0.00698813347249515
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39587,0.00700930770029227,0.00537923353896143,-0.00353399003607214,0.0175526054366567,0.192583278163699
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23523.Concentration of IDL Particles,39587,-0.0344626963797989,0.00561567629586682,-0.0454694219196979,-0.0234559708398999,8.61791147861148e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23524.Total Lipids in IDL,39587,-0.0442844311218708,0.00573940798926033,-0.055533670780821,-0.0330351914629205,1.27361133857543e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23525.Phospholipids in IDL,39587,-0.0411198305610851,0.00573788604512807,-0.0523660872095361,-0.0298735739126341,8.04309285580595e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23526.Cholesterol in IDL,39587,-0.0483286832296238,0.00577394037665539,-0.0596456063678683,-0.0370117600913792,6.23435677829345e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39587,-0.0485066450796668,0.00576476557362701,-0.0598055856039757,-0.0372077045553579,4.28772885780534e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23528.Free Cholesterol in IDL,39587,-0.0465127256262226,0.00577613286303935,-0.0578339460377797,-0.0351915052146654,8.68374038818683e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23529.Triglycerides in IDL,39587,0.00424221683043132,0.0053063821188127,-0.00615829212244157,0.0146427257833042,0.42403836366502
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23530.Concentration of Large LDL Particles,39587,-0.042699954477715,0.00548106815035549,-0.0534428480524118,-0.0319570609030183,7.09254605052874e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23531.Total Lipids in Large LDL,39587,-0.0538141241239167,0.00549620148584192,-0.0645866790361668,-0.0430415692116665,1.42569925351014e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23532.Phospholipids in Large LDL,39587,-0.0535185720969074,0.00551514274969739,-0.0643282518863142,-0.0427088923075005,3.34816791188399e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23533.Cholesterol in Large LDL,39587,-0.0560211606695694,0.00550427310343489,-0.0668095359523017,-0.045232785386837,2.96336804387468e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39587,-0.0550708185094656,0.00547317846593188,-0.0657982483026921,-0.0443433887162391,9.60147735848698e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39587,-0.057228250593524,0.00559748599731067,-0.0681993231482529,-0.0462571780387951,1.84802427687924e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23536.Triglycerides in Large LDL,39587,-0.00427595890005862,0.00532364699577694,-0.0147103070117814,0.00615838921166419,0.42187067252345
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39587,-0.0386439951968059,0.00545011504466874,-0.0493262206843567,-0.0279617697092552,1.39323460561365e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23538.Total Lipids in Medium LDL,39587,-0.0482001365607341,0.00541919935350719,-0.0588217672936082,-0.03757850582786,6.50620686139679e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23539.Phospholipids in Medium LDL,39587,-0.0496438267963435,0.00540981380243412,-0.0602470618491144,-0.0390405917435727,4.99020745808684e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23540.Cholesterol in Medium LDL,39587,-0.0497507419175619,0.00542045838326127,-0.060374840348754,-0.0391266434863698,4.91232021121967e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39587,-0.0462398777298368,0.00542916970510147,-0.0568810503518357,-0.0355987051078379,1.78488270067602e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39587,-0.0562680661175722,0.00541954090153644,-0.0668903662845836,-0.0456457659505607,3.59439352366168e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23543.Triglycerides in Medium LDL,39587,-0.00506812931685891,0.00539988510117494,-0.0156519041151618,0.00551564548144398,0.347969860025988
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23544.Concentration of Small LDL Particles,39587,-0.0330033859185363,0.00547609405264212,-0.0437365302617148,-0.0222702415753577,1.7095946528735e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23545.Total Lipids in Small LDL,39587,-0.0449642603837776,0.00545891716043404,-0.0556637380182283,-0.0342647827493268,1.90599302138577e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23546.Phospholipids in Small LDL,39587,-0.0472526534610924,0.00546650094903208,-0.0579669953211952,-0.0365383116009895,5.94182817106654e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23547.Cholesterol in Small LDL,39587,-0.0467136952119698,0.00545166348692656,-0.0573989556463458,-0.0360284347775937,1.14253171963024e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39587,-0.0424977752248171,0.00545472369810009,-0.0531890336730933,-0.0318065167765409,7.06128731295285e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39587,-0.0528564478154856,0.00543646960800949,-0.0635119282471842,-0.042200967383787,2.79157844803879e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23550.Triglycerides in Small LDL,39587,0.00182426649364876,0.00547314520994212,-0.00890309811783779,0.0125516311051353,0.738903016181821
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39587,-0.00270879805249793,0.00639536474487212,-0.0152437129524473,0.00982611684745143,0.671895106580947
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39587,0.00300616273704409,0.00641563095128139,-0.00956847392746744,0.0155807994015556,0.639384573240301
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39587,0.00972982833687277,0.0063449364354306,-0.0027062470765712,0.0221659037503167,0.125177931543333
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39587,-0.00806602579232543,0.00650966206351132,-0.0208249634368076,0.00469291185215677,0.215332445985567
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39587,-0.0130758180040653,0.00658707696875907,-0.0259864888628331,-0.00016514714529757,0.047153872842092
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39587,0.00846499322218687,0.00612712606393288,-0.00354417386312157,0.0204741603074953,0.167126421780142
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39587,0.0150521953489228,0.00521459534128372,0.00483158848000669,0.0252728022178389,0.00390019824117024
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23558.Concentration of Large HDL Particles,39587,-0.0188161081724389,0.00655093107418855,-0.0316559330778485,-0.00597628326702936,0.00408066600812201
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23559.Total Lipids in Large HDL,39587,-0.0139482122996872,0.00645874077363055,-0.0266073442160031,-0.00128908038337133,0.0308197256684152
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23560.Phospholipids in Large HDL,39587,-0.0101939861913551,0.00632540095639146,-0.0225917720658824,0.00220379968317214,0.107070109639791
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23561.Cholesterol in Large HDL,39587,-0.0214649171656222,0.00660673874764269,-0.0344141251110019,-0.00851570922024252,0.00116077885073182
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39587,-0.0239367895964238,0.00661843903667709,-0.0369089301083109,-0.0109646490845367,0.000299337239070244
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39587,-0.012578766309276,0.0065220315349136,-0.0253619481177066,0.000204415499154688,0.0537913471415404
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23564.Triglycerides in Large HDL,39587,0.0201944246945271,0.00526318049783319,0.00987859091877405,0.0305102584702801,0.000125071831808916
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39587,-0.0331656352911929,0.00576086633403442,-0.0444569333059004,-0.0218743372764855,8.71893067406317e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23566.Total Lipids in Medium HDL,39587,-0.0303814350470102,0.00566859586334945,-0.0414918829391751,-0.0192709871548453,8.4580018144779e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23567.Phospholipids in Medium HDL,39587,-0.0254548096256208,0.00557632409736567,-0.0363844048564575,-0.0145252143947841,5.03755808339338e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23568.Cholesterol in Medium HDL,39587,-0.0393552195189952,0.0058458460186365,-0.0508130777155228,-0.0278973613224677,1.72936606075544e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39587,-0.0402622573920322,0.00583373369471543,-0.0516963754336744,-0.0288281393503899,5.33741222552181e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39587,-0.0343371854639626,0.00586437518199779,-0.0458313608206783,-0.0228430101072469,4.85883212995684e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23571.Triglycerides in Medium HDL,39587,0.0112315587401329,0.0053127011979844,0.000818664392083439,0.0216444530881823,0.0345227911499328
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23572.Concentration of Small HDL Particles,39587,-0.0580740533960003,0.00524338325277108,-0.0683510845714316,-0.047797022220569,2.09657741039261e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23573.Total Lipids in Small HDL,39587,-0.0459454413628324,0.00527307822087747,-0.0562806746757523,-0.0356102080499126,3.24410457813725e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23574.Phospholipids in Small HDL,39587,-0.0392786658656331,0.00528434045306541,-0.0496359731536413,-0.0289213585776249,1.11595640142153e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23575.Cholesterol in Small HDL,39587,-0.0593494927603835,0.00523740860005494,-0.0696148136164912,-0.0490841719042758,1.1892634255062e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39587,-0.0602114897125934,0.00521888675101367,-0.0704405077445802,-0.0499824716806066,1.13797119163559e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39587,-0.0474989294204182,0.00532905178583013,-0.0579438709206453,-0.0370539879201912,5.49295766366592e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23578.Triglycerides in Small HDL,39587,0.00538472936334567,0.00571583263576859,-0.00581830260276076,0.0165877613294521,0.346169937407324
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38841,-0.00164766388186227,0.00536399264493742,-0.0121610894659396,0.00886576170221507,0.758717360100643
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38841,-0.00695486776447856,0.00536123081974308,-0.017462880171175,0.00355314464221788,0.194564447698319
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38841,-0.0015307915193602,0.00531062042523665,-0.011939607552824,0.00887802451410363,0.773158618594964
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38841,-0.0135801679489389,0.0054483239456047,-0.0242588828823241,-0.00290145301555367,0.0126940043364679
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38841,0.00499983433981427,0.0052551129368925,-0.00530018701649503,0.0152998556961236,0.341405132697254
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39401,-0.000275437203068434,0.00520531521751576,-0.0104778550293993,0.00992698062326245,0.95780062702403
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39401,-0.0121339623404885,0.00580569292933506,-0.0235131204819852,-0.000754804198991809,0.0366330206216283
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39401,-0.0135445139661858,0.00578369821758966,-0.0248805624726615,-0.00220846545971006,0.0192013376544757
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39401,-0.00364689566833779,0.00556301140101428,-0.0145503980143258,0.0072566066776502,0.512116057753393
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39401,0.00796263395807319,0.00563960753993077,-0.00309099682019111,0.0190162647363375,0.157995665938958
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39583,0.0161327822547711,0.00564619472633651,0.00506624059115154,0.0271993239183907,0.00427843932971229
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39583,-0.00938366523006425,0.00544426012765369,-0.0200544150802655,0.00128708462013698,0.0848017790255979
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39583,-0.0102762136281152,0.00567198891312909,-0.0213933118978483,0.000840884641617773,0.0700442394884203
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39583,-0.00638906086507015,0.00530739401770157,-0.0167915531397652,0.00401343140962492,0.228683559744984
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39583,0.00381787996751312,0.00523126564895522,-0.0064354007044391,0.0140711606394654,0.46551136239876
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39587,-0.0242699433050458,0.00571683986208785,-0.035474949434738,-0.0130649371753536,2.19512076213178e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39587,-0.0231307850058321,0.0059533696157927,-0.0347993894527858,-0.0114621805588784,0.000102611216659439
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39587,-0.0212276165871289,0.00597293170708073,-0.0329345627330071,-0.00952067044125067,0.000380575473233127
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39587,-0.02752441712992,0.00584182219345368,-0.0389743886290892,-0.0160744456307508,2.47864192364437e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39587,0.0235998067072303,0.00591821139548375,0.0120001123720822,0.0351995010423785,6.70303193339212e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39587,-0.0392792306968978,0.00567510464276928,-0.0504024357967256,-0.02815602559707,4.64735452200311e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39587,-0.0263232094312761,0.00550159530298627,-0.0371063362251292,-0.015540082637423,1.72840485862315e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39587,-0.015546098330148,0.00535620421542622,-0.0260442585923834,-0.00504793806791264,0.00370774088817451
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39587,-0.038127775071268,0.00571634481640543,-0.0493318109114227,-0.0269237392311134,2.64410512625081e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39587,0.0305909100536264,0.00555599120868012,0.0197011672846133,0.0414806528226394,3.72971516368263e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39587,0.0421689259022109,0.0055330848795386,0.0313240795383152,0.0530137722661065,2.6555827139014e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39587,-0.0329350710230739,0.00583500080859928,-0.0443716726079285,-0.0214984694382193,1.68620466880809e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39587,-0.0330029956157217,0.0058995574456074,-0.0445661282091122,-0.0214398630223312,2.25403154949834e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39587,-0.0266935956654463,0.00532459315519837,-0.0371297982496351,-0.0162573930812575,5.40961469767161e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39587,0.0265523312805432,0.00578442440770886,0.0152148594414338,0.0378898031196525,4.46002352894065e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39587,0.0296061077458852,0.00534455562000199,0.0191307787306813,0.0400814367610891,3.08220545375697e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39587,-0.0437252625169479,0.0055896557974349,-0.0546809878799203,-0.0327695371539755,5.50438721170436e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39587,-0.040222789549667,0.00551400209802844,-0.0510302336618027,-0.0294153454375312,3.13684218152554e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39587,-0.0237508947702944,0.00548664054612623,-0.0345047102407018,-0.012997079299887,1.50810090188322e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39587,0.0430797972952713,0.00564914574398263,0.0320074716370653,0.0541521229534772,2.56165308582694e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39587,0.0140082519991975,0.00534465160095022,0.0035327348613351,0.02448376913706,0.00877604435442251
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39587,-0.0573329101921293,0.00559070586553848,-0.0682906936885847,-0.0463751266956739,1.34261306566284e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39587,-0.045147251965778,0.00526295989443666,-0.0554626533588739,-0.0348318505726822,1.05155974126626e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39587,-0.0267760135552355,0.00592326836900673,-0.0383856195584887,-0.0151664075519824,6.21499004277759e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39587,0.0487119674793282,0.0054755345256355,0.0379799198090827,0.0594440151495738,6.39257537994029e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39587,-0.000277522874936572,0.00529279833201951,-0.0106514076056948,0.0100963618558217,0.958183505997645
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39587,-0.0441039229322456,0.00551020946739463,-0.0549039334883391,-0.0333039123761521,1.2875911303374e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39587,-0.0114890944728702,0.00547619007045345,-0.022222427010959,-0.000755761934781421,0.0359202899869202
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39587,-0.0254845386025371,0.00574148066139941,-0.0367378406988799,-0.0142312365061943,9.11322055122289e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39587,0.0475817007598939,0.00535702834653908,0.0370819252006773,0.0580814763191105,7.25846930856777e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39587,0.00482238135714596,0.0054121074443447,-0.00578534923376966,0.0154301119480616,0.372923608521348
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39587,-0.0362663461762332,0.00532699806834006,-0.0467072623901797,-0.0258254299622867,1.02526151414702e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39587,-0.009476028909045,0.00541788114348725,-0.02009507595028,0.00114301813219002,0.080305587815334
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39587,-0.0288990329788512,0.0054678483608565,-0.0396160157661299,-0.0181820501915725,1.27198294086417e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39587,0.0395065861558517,0.00549976420951572,0.0287270483052009,0.0502861240065025,7.10870536396981e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39582,0.0304394427276126,0.00603125963511182,0.0186181738427934,0.0422607116124317,4.53940013355859e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39582,-0.0368209810854421,0.00554444074865763,-0.047688084952811,-0.0259538772180731,3.2163897554703e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39582,-0.0543915845650456,0.00526593423957914,-0.0647128156746208,-0.0440703534554705,6.26285065053743e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39582,0.0112922094938298,0.00635508785906333,-0.00116376270993432,0.0237481816975939,0.0756078087884106
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39582,0.0114941996155283,0.00588752058324208,-4.53407276261829e-05,0.0230337399586828,0.0509204586725504
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39587,0.0274943978286333,0.00593228093407178,0.0158671271978526,0.039121668459414,3.60309983141551e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39587,-0.0339754172449366,0.00603302529562572,-0.045800146824363,-0.0221506876655102,1.8162901842031e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39587,-0.0384002425384312,0.00582404774916606,-0.0498153761267967,-0.0269851089500657,4.43575122602318e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39587,-0.000554609704917997,0.00594499141686662,-0.0122067928819766,0.0110975734721406,0.925674170105992
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39587,0.0313480404089289,0.00571321295390128,0.0201501430192824,0.0425459377985754,4.1528178677666e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39587,0.0465776270834289,0.00596129820419555,0.0348934826032056,0.0582617715636521,5.91976612768501e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39587,-0.0408637169954643,0.00583798539373827,-0.0523061683671913,-0.0294212656237373,2.67018606682006e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39587,-0.0366124209920616,0.00558418546434995,-0.0475574245021875,-0.0256674174819357,5.68209389121513e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39587,-0.035778868885104,0.00630293038746575,-0.0481326124445369,-0.0234251253256711,1.3986783149646e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39587,0.0335562028876241,0.00567773183115525,0.0224278484985598,0.0446845572766884,3.48878780576525e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39587,0.0383795655556288,0.005320837549046,0.0279507239594986,0.0488084071517589,5.71984233676246e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39587,-0.0452467974017128,0.00529100830871143,-0.0556171736867872,-0.0348764211166384,1.3238996560086e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39587,-0.0430595824485416,0.00519700604991403,-0.0532457143063731,-0.0328734505907101,1.27053540617429e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39587,-0.0102466079169651,0.00576808759922336,-0.0215520596114428,0.00105884377751274,0.0756812815483093
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39587,0.0327247358558292,0.00581273084774698,0.0213317833942452,0.0441176883174133,1.83460375876779e-08
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51189,-0.0102700352530182,0.00452160342607518,-0.0191323779681256,-0.00140769253791088,0.0231349940301062
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51189,-0.00785752295501055,0.00442039156117698,-0.0165214904149174,0.00080644450489633,0.0754868298923509
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49267,0.00124772906323531,0.00426064912618217,-0.00710314322408175,0.00959860135055237,0.769639564630776
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49267,-0.0060739423458471,0.00459805826152178,-0.0150861365384298,0.00293825184673559,0.186519977639936
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49267,-0.00805851330638045,0.00456828149176134,-0.0170123450302327,0.000895318417471766,0.077741608399614
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49267,0.00488959195804478,0.00422016010685723,-0.0033819218513954,0.013161105767485,0.246619098695224
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24009.Traffic intensity on the nearest road,51189,-0.00644794109861269,0.0377273714362428,-0.0803935891136487,0.0674977069164233,0.8642967148847
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24010.Inverse distance to the nearest road,51189,-0.00229124648469725,0.00395140766299672,-0.0100360055041708,0.00545351253477633,0.56201667321212
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24011.Traffic intensity on the nearest major road,51189,-3.59790344472072e-05,0.00399444959876944,-0.0078651002480353,0.00779314217914089,0.992813411558852
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24012.Inverse distance to the nearest major road,51189,-0.000190553640493368,0.00404640153493395,-0.00812150064896391,0.00774039336797718,0.96244014907299
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24013.Total traffic load on major roads,51189,0.0182448738425238,0.0263039240118455,-0.0333108172206933,0.069800564905741,0.487927729262347
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24015.Sum of road length of major roads within 100m,51189,0.0135656825869359,0.0255020160423196,-0.0364182688560106,0.0635496340298824,0.59476806931574
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51189,-0.0134351987893634,0.0045344108415542,-0.0223226440388096,-0.00454775353991717,0.0030497588263697
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51189,-0.0134533018569678,0.00453256377670169,-0.0223371268593031,-0.00456947685463249,0.00299863655265444
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51189,-0.0119857478497799,0.00448765579909152,-0.0207815532159992,-0.00318994248356049,0.00757096516035682
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51141,-0.00437336793716361,0.00435664219494155,-0.0129123866392491,0.00416565076492184,0.315465060650034
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24020.Average daytime sound level of noise pollution,51189,-0.00168360807471899,0.00395377308104099,-0.00943300331355933,0.00606578716412135,0.670240076229276
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24021.Average evening sound level of noise pollution,51189,-0.00176460817582111,0.00395291211334483,-0.00951231591797699,0.00598309956633476,0.655306715977589
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24022.Average night-time sound level of noise pollution,51189,-0.00168911518844183,0.00395381434597996,-0.00943859130656255,0.00606036092967888,0.669228609009646
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51189,-0.00168822118002073,0.00395346281041794,-0.00943700828843989,0.00606056592839842,0.669365639060813
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51189,-0.00169061373199522,0.00395351542837502,-0.00943950397161025,0.00605827650761982,0.668929060233498
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2405.Number of children fathered,36077,0.00247210346906376,0.0282244363344259,-0.052847791746411,0.0577919986845385,0.930206095511723
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48082,0.00999858319119978,0.00470092531126411,0.000784769581122131,0.0192123968012774,0.0334351970202161
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48082,-0.00311028039675258,0.0042938170473069,-0.0115261618094741,0.00530560101596895,0.46885016265538
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24502.Water percentage, buffer 1000m",48082,-0.000589500649566962,0.00419368200634897,-0.00880911738201094,0.00763011608287702,0.888211803542795
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48082,0.00689226590545316,0.0044431568592737,-0.00181632153872329,0.0156008533496296,0.120864617099964
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48082,-0.00476894562364331,0.00434325549307945,-0.013281726390079,0.00374383514279241,0.272210267131572
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24505.Water percentage, buffer 300m",48082,0.00305300428817915,0.00421337592653912,-0.00520521252783752,0.0113112211041958,0.46870560969366
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51284,0.00809689637072884,0.00445576268245874,-0.000636398486890285,0.016830191228348,0.0692013743012959
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51284,0.0077349896071944,0.00421004849432912,-0.000516705441690675,0.0159866846560795,0.0661810767654086
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24508.Distance (Euclidean) to coast,51284,-0.00192178401322767,0.0040291054334353,-0.00981883066276086,0.00597526263630551,0.633383468498401
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28601,-0.0263527756343651,0.0441089771833366,-0.112806370913705,0.0601008196449747,0.550237522114326
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2704.Years since last cervical smear test,35411,0.0271084164351593,0.0266621579699699,-0.0251494131859816,0.0793662460563002,0.30929960587469
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2714.Age when periods started (menarche),38708,0.0111592799912194,0.0233997867066281,-0.0347043019537717,0.0570228619362104,0.633442733025757
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2734.Number of live births,39176,0.0695847805918551,0.0222483148935091,0.0259780834005772,0.113191477783133,0.00176544537179177
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2744.Birth weight of first child,35352,0.00245278417479227,0.0255031080149859,-0.0475333075345801,0.0524388758841646,0.923382555223494
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2754.Age at first live birth,33366,-0.00561777284258317,0.00671419929356882,-0.0187776034579781,0.00754205777281172,0.402782057360004
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2764.Age at last live birth,33344,-0.00457172360456924,0.00672484165795194,-0.017752413254155,0.00860896604501655,0.496631100882734
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2794.Age started oral contraceptive pill,36921,0.00468865217375786,0.00668565812987953,-0.00841523776080602,0.0177925421083217,0.483128295440964
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2804.Age when last used oral contraceptive pill,35758,-0.0108258794447621,0.00592880086316517,-0.0224463291365658,0.000794570247041649,0.0678781278846718
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2867.Age started smoking in former smokers,29235,0.00383745019793643,0.00904936333229004,-0.013899301933352,0.0215742023292249,0.671540865090385
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36283,-0.00621404351273501,0.0304815543868743,-0.0659578901110087,0.0535298030855387,0.838464350789145
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36279,0.0195037804466086,0.0338886004219777,-0.0469178763804677,0.0859254372736849,0.564945845446373
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36298,-0.00685407741231898,0.034689670828812,-0.0748458322367905,0.0611376774121525,0.843374832438456
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36270,-0.0287545608125442,0.033688147820269,-0.0947833305402715,0.0372742089151831,0.393370154546785
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28739.Difficulty with standing for long periods,36309,0.0153003336428996,0.0319372612533243,-0.047296698413616,0.0778973656994153,0.631893908991441
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28740.Difficulty with taking care of household responsibilities,36332,0.0530429162467891,0.0356887395588292,-0.0169070132885161,0.122992845782094,0.137234384815794
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28741.Difficulty learning a new task,36237,0.0521510680983939,0.040059795498792,-0.0263661310792385,0.130668267276026,0.192998530492013
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28742.Difficulty with joining in community activities,35799,0.00900179269393765,0.0383084668855709,-0.0660828024017812,0.0840863877896565,0.814226886314111
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28743.Difficulty with being emotionally affected by health problems,36248,-0.0196478646459489,0.0328999249384238,-0.0841317175252596,0.0448359882333617,0.550384178612333
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36330,0.0247965650742522,0.045049967724219,-0.0635013716652171,0.113094501813721,0.582038732333928
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29082,0.0530557396383316,0.040551344103717,-0.0264248948049538,0.132536374081617,0.19080896857642
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2897.Age stopped smoking,29240,0.0175256280051632,0.0109608590593774,-0.00395765575121647,0.0390089117615428,0.109895250914
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34987,-0.0145910921792421,0.0129379435831482,-0.0399494616022126,0.0107672772437284,0.259439178053115
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34987,0.00805419847623971,0.0138948646567978,-0.0191797362510841,0.0352881332035635,0.562160453038456
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34987,0.0242497764158222,0.0465556652273661,-0.0669993274298153,0.11549888026146,0.602462806000585
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34987,0.00117038820492986,0.0458564076436739,-0.0887081707766711,0.0910489471865308,0.979638345811659
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34987,0.0934218975307928,0.0499129502466978,-0.00440748495273484,0.191251280014321,0.061274810090087
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34987,0.00695952049022341,0.0425629772899363,-0.0764639149980517,0.0903829559784985,0.870118980625971
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34987,0.0281727815252268,0.0192675097890964,-0.00959153766140221,0.0659371007118558,0.143717088707513
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34987,0.0573496815517388,0.0357221294398962,-0.0126656921504577,0.127365055253935,0.108425717413549
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29002.Recent lack of interest or pleasure in doing things,34916,-0.0159821720171854,0.0346682717735972,-0.0839319846934358,0.0519676406590651,0.644805631763603
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29003.Recent feelings of depression,34913,-0.043651443807896,0.0335808677038525,-0.109469944507447,0.0221670568916548,0.193665686225331
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34922,0.0341365186324851,0.0277185214360832,-0.020191783382238,0.0884648206472082,0.218146466320505
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29005.Recent feelings of tiredness or low energy,34927,0.0341677795116733,0.0281025818646492,-0.0209132809430392,0.0892488399663858,0.224078101805881
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29006.Recent poor appetite or overeating,34929,0.0072859192919651,0.0370071905883294,-0.0652481742611605,0.0798200128450907,0.84392625279463
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29007.Recent feelings of inadequacy,34895,0.00891049021747006,0.0358561789253333,-0.0613676204761833,0.0791886009111234,0.803747238176105
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29008.Recent trouble concentrating on things,34927,0.0113028113875309,0.0358541365249244,-0.058971296201321,0.0815769189763828,0.752582133859037
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34918,-0.0250635024230028,0.0641755405398655,-0.150847561881139,0.100720557035134,0.696140351462224
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29010.Recent thoughts of suicide or self-harm,34855,0.0659575388623058,0.0704991517311333,-0.0722207985307153,0.204135876255327,0.349510447328681
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#0.Substances taken for depression_None of options listed,32596,0.0216397781617337,0.0241372438255087,-0.0256692197362634,0.0689487760597308,0.369994138297168
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32596,-0.0121805756116903,0.0428157519949906,-0.0960994495218719,0.0717382982984913,0.776043029438492
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32596,-0.0272324885932406,0.023814801475624,-0.0739094994854636,0.0194445222989824,0.252857804116102
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32596,-0.130810189570221,0.070092918158359,-0.268192309160605,0.0065719300201626,0.0620413127134117
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32596,-0.0499513797772308,0.0407882625898792,-0.129896374453394,0.0299936148989324,0.220739827683008
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32596,-0.0921269747591411,0.0440220101378058,-0.178410114629241,-0.00584383488904172,0.036400431221208
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32596,-0.0577681624150929,0.0493814183265472,-0.154555742335125,0.0390194175049396,0.242098875125033
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32596,-0.0551763886277737,0.0604405144424539,-0.173639796934983,0.063287019679436,0.361318215172371
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32596,0.029388958437579,0.0487749303047922,-0.0662099049598136,0.124987821834972,0.546828858035637
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32596,-0.000622219708900219,0.0244899909038227,-0.0486226018803927,0.0473781624625922,0.979730826274399
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32596,-0.0298891454656323,0.0358617096802464,-0.100178096438915,0.0403998055076506,0.404610572539518
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32596,-0.112942483398838,0.0563087731729233,-0.223307678817767,-0.00257728797990804,0.0449115034556722
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32596,-0.00957725571544995,0.0700803450769894,-0.146934732066349,0.127780220635449,0.891301842791365
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32596,0.000835899532719107,0.0429264040627277,-0.0832998524302273,0.0849716514956655,0.984464338245198
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32596,-0.0804185849584814,0.0730800702086189,-0.223655522567375,0.0628183526504116,0.271180596705361
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32596,-0.0507729732885807,0.0693064205299512,-0.186613557527285,0.0850676109501238,0.463830099685275
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32596,0.030771386890437,0.0375999000532829,-0.0429244172139975,0.104467190994871,0.413156780915329
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32596,-0.00433032251856367,0.0368277043220373,-0.0765126229897567,0.0678519779526294,0.906400551426513
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32596,-0.0898964374536169,0.0520644992927874,-0.19194285606748,0.0121499811602463,0.0842684130048785
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29058.Recent feelings or nervousness or anxiety,34755,0.0358046015008364,0.0323245605058336,-0.0275515370905974,0.0991607400922701,0.268033421064431
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29059.Recent inability to stop or control worrying,34760,0.0363396505742526,0.033999803503647,-0.0302999642928954,0.102979265441401,0.285174716051023
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29060.Recent worrying too much about different things,34752,0.0458102543374534,0.031121287854274,-0.0151874698569236,0.10680797853183,0.14105221653634
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29061.Recent trouble relaxing,34757,0.0265428861481623,0.0324665067653243,-0.0370914671118733,0.0901772394081979,0.413633938701319
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29062.Recent restlessness,34761,0.113663773395465,0.0460244052021594,0.0234559391992326,0.203871607591697,0.0135400640286655
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29063.Recent easy annoyance or irritability,34744,-0.0112509219977201,0.0327693223185864,-0.0754787937421496,0.0529769497467093,0.731351554139882
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29064.Recent feelings of foreboding,34735,0.0138228793716958,0.0376074783503773,-0.0598877781950438,0.0875335369384353,0.713210985402979
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32596,-0.0246133563804973,0.0244230977567091,-0.0724826279836471,0.0232559152226525,0.313583146904247
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32596,-0.0484659026959703,0.0401759943830514,-0.127210851686751,0.0302790462948104,0.22771914904557
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32596,-0.0260614550575493,0.0528466172368904,-0.129640824841854,0.0775179147267558,0.621917050845079
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32596,-0.0673822194207604,0.0590002246656175,-0.183022659765371,0.0482582209238499,0.253457402897054
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#2.Symptoms of panic attack_Sweating,32596,-0.00916584707789852,0.0365718536388398,-0.0808466802100246,0.0625149860542275,0.802109390001118
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32596,-0.0694460164812635,0.0394340157841758,-0.146736687418248,0.007844654455721,0.0782617321472593
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32596,0.0341783116769873,0.0397229031482852,-0.0436785784936516,0.112035201847626,0.389582129513408
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32596,-0.0690640091402388,0.0357476057337425,-0.139129316378374,0.00100129809789645,0.053393063923741
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32596,-0.0622021543999096,0.0487545243192691,-0.157761022065677,0.0333567132658579,0.202051937000803
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29076.Felt loved as a child,34711,-0.0174452394064069,0.0291212572970015,-0.0745229037085299,0.039632424895716,0.549148612291704
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29077.Physically abused by family as a child,34714,-0.00287527102156581,0.0370683910900479,-0.0755293175580597,0.0697787755149281,0.938174199783267
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29078.Felt hated by family member as a child,34700,0.018917169674862,0.0379689918934759,-0.0555020544363507,0.0933363937860748,0.618334299294821
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29079.Sexually molested as a child,34620,0.034034772633882,0.0517366696413631,-0.0673690998631896,0.135438645130954,0.510651027143561
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29080.Someone to take to doctor when needed as a child,34696,-0.0515663769361173,0.0438843034711661,-0.137579611739603,0.0344468578673683,0.239999389241078
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34701,0.084426571401742,0.0517186781489361,-0.0169420377701727,0.185795180573657,0.102620219064492
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34640,0.0464418994918031,0.0408685601528103,-0.0336604784077051,0.126544277391311,0.255826049033358
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34709,0.0555808129408655,0.045242956494023,-0.0330953817874196,0.144257007669151,0.219287299561915
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34672,0.0831668717462185,0.0639662176530665,-0.0422069148537918,0.208540658346229,0.193570885480286
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34673,0.122127915387632,0.0625739047965477,-0.00051693801360167,0.244772768788865,0.0509950101655434
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29086.Experienced a violent or sexual assault,34708,-0.0344535031468395,0.0496932038800216,-0.131852182751682,0.0629451764580028,0.488120935188801
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29087.Experienced a life-threatening injury or illness,34715,0.0516870929096561,0.0352433370274623,-0.01738984766417,0.120764033483482,0.142519935199224
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29088.Experienced a marital separation or divorce,34717,0.0644911481376176,0.0312748250840547,0.00319249097287032,0.125789805302365,0.0392239943788683
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29089.Experienced the death of a spouse or partner,34729,-0.0044098905519639,0.0498327729237302,-0.102082125482475,0.0932623443785472,0.92948585658046
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34713,0.0406429863846122,0.0388461737385298,-0.0354955141429063,0.116781486912131,0.295466821948625
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29091.Frequency of drinking alcohol,34720,-0.0454047464293084,0.0260912293617906,-0.096543555978418,0.00573406311980108,0.0818469306366964
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33636,-0.0379252476918014,0.029035769349422,-0.0948353556166685,0.0189848602330657,0.191530213497612
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33650,-0.0635518896810915,0.0291011888671456,-0.120590219860697,-0.00651355950148614,0.0289988049151657
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29104.Ever used cannabis,34707,0.0113374231391786,0.0342953234939934,-0.0558814109090485,0.0785562571874057,0.740966487730529
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29108.Ever thought that life not worth living,34658,0.0159703022748889,0.0319329222022514,-0.0466182252415238,0.0785588297913017,0.617000573527826
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29109.Ever contemplated self-harm,34677,-0.013406251584084,0.0413741150235963,-0.0944995170303328,0.0676870138621648,0.745925300022997
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29111.Ever self-harmed,34695,0.0208908598265301,0.0649282935814006,-0.106368595593015,0.148150315246075,0.747646186843137
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34702,-0.0525023759123585,0.044709051457044,-0.140132116768165,0.0351273649434477,0.240295870773681
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33273,-0.049812275434295,0.0501092343468891,-0.148026374754198,0.0484018238856076,0.320212507388193
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33273,-0.00753943544049313,0.03905357742446,-0.0840844471924346,0.0690055763114484,0.846921121295036
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33273,-0.011551821202499,0.0410146634718889,-0.0919405616074013,0.0688369192024033,0.778217317427724
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33273,-0.0135136863429673,0.0545380599850486,-0.120408283913663,0.0933809112277278,0.804306546918685
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34696,-0.0367107235214471,0.0292221440243,-0.093986125809075,0.0205646787661809,0.209047404851683
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X29153.Pain or discomfort today,34710,0.0258541363282651,0.0281147489001468,-0.0292507715160225,0.0809590441725528,0.357805748525689
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29154.Anxiety or depression today,34710,-0.00568814684791119,0.0345191389158059,-0.0733456591228907,0.0619693654270683,0.869118321322639
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29166.Frequency of confiding in someone close,34468,0.0162092454421478,0.0274084598628787,-0.0375113358890944,0.0699298267733899,0.554267923826009
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34675,-0.00473326054371978,0.0133979757662274,-0.0309932930455255,0.021526771958086,0.723884099396911
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34675,-0.0129696957656606,0.0133213592518389,-0.0390795598992649,0.0131401683679437,0.330276200736213
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34675,-0.00514833520555957,0.0165400554196798,-0.0375668438281321,0.0272701734170129,0.755605408273132
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34675,0.00471785462712554,0.019817926495196,-0.0341252813034587,0.0435609905577097,0.811839105569582
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34675,-0.0589874007067398,0.030553138959014,-0.118871553066407,0.000896751652927685,0.0535525284462238
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34675,0.000881883689579177,0.0144403966812489,-0.0274212938056686,0.029185061184827,0.951304111696678
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34675,0.0146240077257282,0.0157780219362407,-0.0163009152693036,0.0455489307207601,0.354020229306798
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34675,-0.00432042522746655,0.0223016216645607,-0.0480316036900055,0.0393907532350724,0.846393323876259
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34675,-0.0149549968758374,0.0358515775521154,-0.0852240888779836,0.0553140951263089,0.676586944159598
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34675,0.0120164624113513,0.035444645373007,-0.0574550425197424,0.081487967342445,0.734600847505259
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34675,-0.0556779897725476,0.0472474699776884,-0.148283030928817,0.0369270513837215,0.238649854428668
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34675,-0.0375319115496158,0.0236889555552134,-0.083962264437834,0.00889844133860242,0.113140309096856
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29171.Frequency of feeling 'in tune' with people,34492,-0.0087710835177769,0.0333926820458618,-0.074220740327666,0.0566785732921122,0.792814008058636
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29172.Freuency of feeling that lacks companionship,34628,0.0409227952504891,0.0308676356900283,-0.0195777707019663,0.101423361202944,0.18495035341397
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29173.Frequency of feeling left out,34584,-0.0184674114545426,0.0314954780811598,-0.0801985484936158,0.0432637255845305,0.55765187135223
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29174.Frequency of feeling isolated from others,34613,-0.0106677898075667,0.032494347450753,-0.0743567108110425,0.0530211311959091,0.742693667537455
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29175.Tendency to bounce back quickly after hard times,34693,0.0108371654277715,0.0273666893719855,-0.0428015457413202,0.0644758765968631,0.692114003566948
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29176.Ability to make it through stressful events,34693,0.00956472513386111,0.0267575267267896,-0.0428800272506465,0.0620094775183688,0.720755001368181
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29177.Quick recovery from stressful events,34693,0.0100116492016559,0.0270293046117971,-0.0429657878374664,0.0629890862407783,0.711091861558718
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29178.Hard to snap back when something bad happens,34693,0.00962564702775037,0.0267891080603918,-0.0428810047706175,0.0621322988261183,0.719368730403588
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29179.Comes through difficult times with little trouble,34693,0.0192322936211216,0.0270955787977706,-0.0338750408225088,0.0723396280647521,0.477846843159446
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29180.Tendency to take a long time to get over setbacks,34693,-0.0109475420320381,0.0270626946530548,-0.0639904235520256,0.0420953394879493,0.685834537670324
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29181.General happiness,34626,-0.00440421175803231,0.0280740654676389,-0.0594293800746046,0.05062095655854,0.875343702343517
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29182.Belief that own life is meaningful,34523,0.0248327873524978,0.0277111476074626,-0.0294810619581289,0.0791466366631244,0.370203636188925
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28779,0.0124909892349029,0.0398496486496526,-0.0656143221184162,0.0905963005882219,0.753949867279212
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2946.Father's age,33890,-0.0110839893257174,0.0097580376636475,-0.0302097431464665,0.00804176449503172,0.256032664128159
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2966.Age high blood pressure diagnosed,28941,-0.0156871468022021,0.0158517560631171,-0.0467565886859116,0.0153822950815073,0.322409112476421
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30000.White blood cell (leukocyte) count,50732,-0.00200402774807921,0.00416252215034556,-0.0101625711627565,0.00615451566659809,0.630203793275086
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50732,0.00777920135086001,0.00491345289576285,-0.00185116632483519,0.0174095690265552,0.113377326331261
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30020.Haemoglobin concentration,50732,0.00505248079597317,0.00524192268455334,-0.00522168766575138,0.0153266492576977,0.335124679359228
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30030.Haematocrit percentage,50732,0.00680679365050726,0.00512903314306482,-0.00324611130989977,0.0168596986109143,0.184483413787166
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30040.Mean corpuscular volume,50732,-0.00115324624955865,0.00415957865834543,-0.00930602041991569,0.00699952792079838,0.781589715949008
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50731,-0.00385083176743196,0.00417039068646325,-0.0120247975128999,0.004323133978036,0.355820447784161
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50731,-0.00623134889947005,0.00406180191486545,-0.0141924806526063,0.00172978285366623,0.125008434433262
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50732,0.0157523934107748,0.00397206326052432,0.00796714942014714,0.0235376374014025,7.33408182919115e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30080.Platelet count,50732,-0.0140566832627765,0.00419588806540127,-0.022280623870963,-0.00583274265458998,0.000808908547783058
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30090.Platelet crit,50732,-0.00460645927189145,0.00430413456891688,-0.0130425630269685,0.00382964448318564,0.284520666989898
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50732,0.018744927925243,0.00403776690139571,0.0108309047985074,0.0266589510519786,3.46012737514137e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30110.Platelet distribution width,50732,0.0164688225829765,0.00400027644094974,0.00862828075871501,0.024309364407238,3.85113515235463e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30120.Lymphocyte count,50694,-0.0062555853430121,0.00423517025550199,-0.014556519043796,0.00204534835777181,0.139672254130396
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30130.Monocyte count,50694,0.0262026111024071,0.00421364002311617,0.0179438766570994,0.0344613455477148,5.09257682998857e-10
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30140.Neutrophill count,50694,-0.00565697249393199,0.00412032429133672,-0.013732808104952,0.00241886311708798,0.169781381701889
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30150.Eosinophill count,50694,0.0251549884966786,0.00403930410535654,0.0172379524501798,0.0330720245431774,4.8079289107397e-10
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30160.Basophill count,50694,0.010908811754664,0.0191134523370612,-0.0265535548259759,0.0483711783353039,0.568180680515386
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30170.Nucleated red blood cell count,50694,0.085674688843016,0.08570906983834,-0.0823150880401304,0.253664465726162,0.317513687098752
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30180.Lymphocyte percentage,50694,-0.00622480530065934,0.00415253896038509,-0.0143637816630141,0.00191417106169544,0.133876062599156
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30190.Monocyte percentage,50694,0.0293706093525329,0.00415770710064959,0.0212215034352597,0.0375197152698061,1.65559183252668e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30200.Neutrophill percentage,50694,-0.00918393656710535,0.0040891195594467,-0.0171986109036209,-0.00116926223058982,0.024715649960012
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30210.Eosinophill percentage,50694,0.0261252861907612,0.00398737623016621,0.0183100287796355,0.033940543601887,5.77996265389608e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30220.Basophill percentage,50694,0.0056212923914693,0.00396889406745673,-0.00215773998074589,0.0134003247636845,0.156688402981684
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30230.Nucleated red blood cell percentage,50693,0.0937212416370013,0.0859436481905955,-0.0747283088165658,0.262170792090568,0.275504317191723
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30240.Reticulocyte percentage,50254,3.42757428355991e-05,0.00426417180066457,-0.00832350098646696,0.00839205247213816,0.993586671982441
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30250.Reticulocyte count,50254,0.00178604861246654,0.00437276666469992,-0.0067845740503453,0.0103566712752784,0.682947976584284
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30260.Mean reticulocyte volume,50254,0.012878907655914,0.00412379549603427,0.00479626848368685,0.0209615468281412,0.00179167841047148
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30270.Mean sphered cell volume,50254,0.0034572053585922,0.00414721614785319,-0.00467133829120005,0.0115857490083845,0.404502283239365
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30280.Immature reticulocyte fraction,50254,-0.00363223670391552,0.00430585117718511,-0.0120717050111983,0.00480723160336729,0.398923892840673
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50254,-0.00141398910730904,0.00436108273698948,-0.00996171127180843,0.00713373305719034,0.74576730464238
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30300.High light scatter reticulocyte count,50254,-0.000203740657817417,0.00443609592207178,-0.00889848866507811,0.00849100734944328,0.963368048316226
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30500.Microalbumin in urine,31901,0.0394922362401343,0.00759794060430519,0.0246002726556961,0.0543841998245725,2.0667004365493e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50843,-0.00652213074145853,0.00422760782425712,-0.0148082420770025,0.00176398059408543,0.122903816820116
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30520.Potassium in urine,50779,-0.00749124351237484,0.00392608151990073,-0.0151863632913803,0.000203876266630579,0.056392627627092
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30530.Sodium in urine,50785,-0.00880366030739421,0.00408193900031664,-0.0168042607480148,-0.000803059866773601,0.0310351493906944
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30600.Albumin,48090,-0.0554229793464066,0.00440398678938773,-0.0640547934536066,-0.0467911652392067,3.32608279236985e-36
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30610.Alkaline phosphatase,50324,0.0648259938938396,0.00415098774184823,0.0566900579198171,0.0729619298678622,9.79259214603616e-55
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30620.Alanine aminotransferase,50315,0.0283663766521937,0.00439636735560623,0.0197494966352055,0.036983256669182,1.12120912361842e-10
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30630.Apolipoprotein A,47958,-0.0533187938897416,0.00479731284444225,-0.0627215270648484,-0.0439160607146348,1.2546455272342e-28
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30640.Apolipoprotein B,50163,-0.039993540988635,0.00421147340146415,-0.0482480288555047,-0.0317390531217653,2.35249012483603e-21
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30650.Aspartate aminotransferase,50235,0.0424892728819731,0.00412410629323322,0.034406024547236,0.0505725212167102,7.6393366178088e-25
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30660.Direct bilirubin,46199,0.0121944585797954,0.0045104638320277,0.0033539494690211,0.0210349676905697,0.00686461454622842
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30670.Urea,50316,0.0126081196797681,0.0043352371957279,0.00411105477614136,0.0211051845833947,0.00363715273764439
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30680.Calcium,48086,-0.0162317748982155,0.00429599471851577,-0.0246519245465064,-0.0078116252499246,0.000158248234971726
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30690.Cholesterol,50329,-0.0517741613856075,0.0043329770068759,-0.0602667963190842,-0.0432815264521307,7.99504797012241e-33
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30700.Creatinine,50319,0.0176099345837708,0.00525850096286554,0.00730327269655432,0.0279165964709872,0.000812607557288713
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30710.C-reactive protein,50247,0.0330237484654201,0.00452600038472064,0.0241527877113676,0.0418947092194726,3.03787213055022e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30720.Cystatin C,50324,0.0979774314016688,0.0048206044962359,0.0885290465890465,0.107425816214291,3.86254947418055e-91
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30730.Gamma glutamyltransferase,50314,0.0202809915427592,0.00448686409851998,0.0114867379096601,0.0290752451758584,6.20835739203241e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30740.Glucose,48052,0.0227184491385478,0.00437610146176385,0.0141412902734907,0.031295608003605,2.10313638222452e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50099,0.0236054922691609,0.00438189607869354,0.0150169759549216,0.0321940085834003,7.22395834466665e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30760.HDL cholesterol,48069,-0.0601001427800369,0.00507611074314495,-0.070049319836601,-0.0501509657234728,2.98330215811208e-32
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30770.IGF-1,50204,-0.03346890290368,0.00427500045507545,-0.0418479037956279,-0.0250899020117321,5.10246037190503e-15
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30780.LDL direct,50274,-0.0432353947507179,0.00429013252021496,-0.0516440544903392,-0.0348267350110966,7.64353051702972e-24
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30790.Lipoprotein A,45048,-0.00678958575856405,0.00454224294230029,-0.0156923819254726,0.00211321040834452,0.134990676857012
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30810.Phosphate,48026,-0.00561502597538019,0.00429759222588958,-0.0140383067381238,0.00280825478736338,0.191377479414354
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30830.SHBG,47847,0.00673917108808037,0.00498597337967555,-0.0030333367360837,0.0165116789122444,0.176507744894976
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30840.Total bilirubin,50227,-0.000125319567768246,0.00421917526542742,-0.00839490308800599,0.00814426395246949,0.976304634675093
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30850.Testosterone,48207,-0.00106736613993403,0.00712319023352872,-0.0150288189976503,0.0128940867177823,0.880889065855392
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30860.Total protein,48071,0.0505317883733588,0.00435405226774722,0.0419978459285743,0.0590657308181433,4.6595709696686e-31
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30870.Triglycerides,50308,0.00797755134003921,0.00432549932417184,-0.000500427335337592,0.016455530015416,0.0651494988034266
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30880.Urate,50296,0.0292790279984278,0.00521584459045905,0.0190559726011281,0.0395020833957276,2.0028711313973e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30890.Vitamin D,49239,-0.00559917392971514,0.00450639185714093,-0.0144317019697114,0.00323335411028109,0.214065089592314
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3137.Number of measurements made,49373,0.0300147364984352,0.0215859406755178,-0.0122937072255797,0.07232318022245,0.164396454485111
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3143.Ankle spacing width,39610,-0.00565465497381982,0.00733660107851137,-0.0200343930877021,0.00872508314006246,0.440869139488475
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39609,-0.0135711317225205,0.0056204523331144,-0.0245872182954247,-0.00255504514961628,0.0157639165711455
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3146.Speed of sound through heel,39610,-0.00857861445612909,0.00546198218582175,-0.0192840995403397,0.00212687062808154,0.116294603933355
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39610,-0.0107707653177761,0.00551480869886542,-0.0215797903675523,3.82597320001121e-05,0.0508298896000918
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3148.Heel bone mineral density (BMD),39600,-0.0109236323159441,0.00552297675110573,-0.0217486667481113,-9.85978837768735e-05,0.0479627834151597
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3526.Mother's age at death,35093,-0.00893935391661993,0.00739121634516118,-0.0234261379531358,0.00554743011989598,0.226513005335787
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3581.Age at menopause (last menstrual period),30250,-0.013469027036744,0.0104115144566346,-0.0338755953717479,0.00693754129825987,0.195827407308998
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30218,-0.00417033396726431,0.00941073585674706,-0.0226153762464886,0.0142747083119599,0.657674903360658
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4100.Ankle spacing width (left),32606,0.0208351144009313,0.00992517581685834,0.00138176979988892,0.0402884590019736,0.0358262172673123
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32605,-0.0164874166418911,0.00765497936276193,-0.0314911761929045,-0.00148365709087773,0.0312818505397131
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4103.Speed of sound through heel (left),32606,-0.0181709541757554,0.00747012286631477,-0.0328123949937323,-0.00352951335777845,0.0150155747648596
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32606,-0.0181699012626657,0.00753728466363011,-0.0329429792033807,-0.00339682332195065,0.0159437699993873
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4105.Heel bone mineral density (BMD) (left),32599,-0.0180997604448464,0.00755075697070325,-0.0328992441074248,-0.00330027678226807,0.0165472329267174
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32606,-0.018188832714443,0.00753737523492123,-0.0329620881748886,-0.00341557725399737,0.0158356474908602
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4119.Ankle spacing width (right),32595,0.0176380256287739,0.00975088477374103,-0.00147370852775847,0.0367497597853064,0.0705064834997292
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32595,-0.00743307164260863,0.0077258007799099,-0.022575641171232,0.00770949788601477,0.336020888934319
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4122.Speed of sound through heel (right),32595,-0.00838361260680997,0.00752175880806134,-0.0231262598706102,0.00635903465699025,0.265060501696694
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32595,-0.00844423398929858,0.00759772565746478,-0.0233357762779296,0.0064473082993324,0.266419910825355
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4124.Heel bone mineral density (BMD) (right),32586,-0.00982680005565031,0.00762395254808626,-0.0247697470498994,0.00511614693859875,0.19745390600479
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32595,-0.00844538684248874,0.00759774832654316,-0.0233369735625133,0.00644619987753584,0.266356063521099
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4194.Pulse rate,32891,0.0164609779613853,0.00722759673244408,0.00229488836579494,0.0306270675569757,0.0227786114408142
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4195.Pulse wave reflection index,32891,-0.00352906254195681,0.00707376621490925,-0.0173936443231789,0.0103355192392653,0.617865911743129
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4196.Pulse wave peak to peak time,32886,-0.00622495395169708,0.00761382548820427,-0.0211480519085774,0.00869814400518329,0.413615443271844
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4198.Position of the pulse wave peak,32891,0.00923237214329054,0.00727132405529406,-0.00501942300508582,0.0234841672916669,0.20422560120077
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4199.Position of pulse wave notch,32891,0.013576260141318,0.00716319905044437,-0.000463609997552957,0.027616130280189,0.0580873625001799
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4200.Position of the shoulder on the pulse waveform,32891,0.0133469209642331,0.00745826985633473,-0.00127128795418296,0.0279651298826492,0.0735603359880787
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4269.Number of triplets attempted (left),32763,0.290650522708115,0.0981451486748146,0.0982860313054783,0.483015014110752,0.00307018372182787
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4270.Volume level set by participant (left),32679,0.0285645594002067,0.0292359397759707,-0.0287378825606959,0.0858670013611094,0.328578244781147
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4276.Number of triplets attempted (right),32771,0.226447105877531,0.0959570635261716,0.0383712613662344,0.414522950388827,0.0183023392379194
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4277.Volume level set by participant (right),32669,0.0212382832989212,0.0291911156280909,-0.035976303332137,0.0784528699299794,0.466902417222812
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4288.Time to answer,32925,-0.00345242816394787,0.00818028883699594,-0.0194857942844599,0.0125809379565642,0.673004128918018
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4290.Duration screen displayed,32925,0.0123013743064186,0.00728875165484519,-0.00198457893707794,0.0265873275499152,0.0914993292142035
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X46.Hand grip strength (left),51536,-0.022957466474051,0.00565223843563236,-0.0340358538078904,-0.0118790791402115,4.88593112517404e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X47.Hand grip strength (right),51509,-0.0220018599073299,0.0056033663666618,-0.0329844579859871,-0.0110192618286728,8.63843498229528e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X48.Waist circumference,51587,0.0230689470964403,0.00885430768823549,0.00571450402749872,0.0404233901653819,0.00918180720274774
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X4803.Tinnitus,32715,0.0615023468143858,0.0367104405901127,-0.0104501167422351,0.133454810371007,0.0939035164964117
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4825.Noisy workplace,32848,0.0420244727503914,0.0404461819985033,-0.0372500439666752,0.121298989467458,0.298822462478416
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4836.Loud music exposure frequency,32785,-0.0233322182875786,0.0434056076002538,-0.108407209184076,0.061742772608919,0.59090857692174
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X49.Hip circumference,51584,-0.0093633148774463,0.00699886997555334,-0.0230811000295308,0.00435447027463825,0.180962057470039
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X50.Standing height,51560,0.0114758813604685,0.00555539299732993,0.000587311085701824,0.0223644516352352,0.0388642897303557
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X5057.Number of older siblings,32073,-0.00108698940487015,0.0309825074273609,-0.0618127039624975,0.0596387251527572,0.972013635211733
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X51.Seated height,51426,0.0117932002178619,0.00515060930918165,0.00169800597186583,0.0218883944638579,0.0220479225240351
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5181.Ever had eye surgery,29977,-0.0169798579769925,0.077097288576044,-0.168090543586039,0.134130827632054,0.825692091393545
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5186.Duration visual-acuity screen displayed (right),29962,0.010646481333181,0.00894676139260403,-0.00688917099632292,0.0281821336626849,0.234099924613257
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5188.Duration visual-acuity screen displayed (left),29960,-0.00261987814306027,0.0088501927902307,-0.0199662560119124,0.0147264997257919,0.767221081442852
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5190.Duration at which refractometer first shown (right),29907,0.00430363747651478,0.0087463298789191,-0.0128391690861667,0.0214464440391962,0.622701385701025
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5193.Duration at which refractometer first shown (left),29905,0.00456637798286602,0.00876795208193477,-0.0126188080977261,0.0217515640634582,0.602522910864055
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5199.logMAR, initial (right)",29939,-0.0436445383613382,0.0365867446260988,-0.115354557828492,0.0280654811058154,0.23295284845732
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5200.Final number of letters displayed (right),29939,0.473140576100496,0.229105160412154,0.0240944616926735,0.922186690508318,0.0389494484719967
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5201.logMAR, final (right)",29885,-0.00684081758693278,0.00847514287709165,-0.0234520976260324,0.00977046245216686,0.419604724783715
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5202.Number of rounds to result (right),29939,-0.0516336994429341,0.0350003059536212,-0.120234299112032,0.0169669002261635,0.14020108022801
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5206.logMAR, initial (left)",29935,0.0209929218150363,0.0364749574594842,-0.0504979948055526,0.0924838384356253,0.564945153764144
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5207.Final number of letters displayed (left),29935,-0.205745150827185,0.24899095051439,-0.693767413835388,0.282277112181019,0.408657447576808
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5208.logMAR, final (left)",29887,0.003652538585694,0.00850634823317398,-0.013019903951327,0.020324981122715,0.667654973910489
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5209.Number of rounds to result (left),29931,0.0133424809922517,0.0347427843906973,-0.054753376413515,0.0814383383980185,0.700965216893274
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29700,-0.0101195422689769,0.00886209114244492,-0.0274892409081689,0.00725015637021514,0.253546139230506
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29700,-0.00545206225530163,0.0087160380165553,-0.02253549676775,0.0116313722571468,0.531653805268434
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5256.Corneal hysteresis (right),29700,0.00622073541637473,0.00889905838900826,-0.0112214190260815,0.0236628898588309,0.484559250317286
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5257.Corneal resistance factor (right),29700,0.00250759514836056,0.00874395811041826,-0.0146305627480592,0.0196457530447803,0.77429070240977
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29679,-0.005126994683537,0.00893070909254541,-0.022631184504926,0.012377195137852,0.565931824421302
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29679,-0.00132700113189798,0.00871043530909942,-0.0183994543377328,0.0157454520739369,0.878919222804235
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5264.Corneal hysteresis (left),29679,0.00812106928786453,0.00888290878172632,-0.00928943192431906,0.0255315705000481,0.360631068623412
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5265.Corneal resistance factor (left),29679,0.00760898929298754,0.00869720913859355,-0.00943754061865583,0.0246555192046309,0.381676876705348
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29779,0.0214425377855792,0.149009681983864,-0.270616438902795,0.313501514473953,0.885584099226011
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51488,0.0178553351903692,0.0242362094905563,-0.0296476354111212,0.0653583057918595,0.461298020636338
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51488,0.0392653459150693,0.0270845334654992,-0.0138203396773092,0.0923510315074477,0.147144299774883
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51488,0.0603658754576992,0.0634478830487355,-0.0639919753178224,0.184723726233221,0.341397210750291
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51488,0.000178705252075977,0.0111525028367975,-0.0216802003080472,0.0220376108121991,0.987215536124787
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51488,-0.0072535083207138,0.00999977423948756,-0.0268530658301094,0.0123460491886818,0.468232928521119
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37593,-0.0201612820463471,0.0112788819028917,-0.0422678905760149,0.0019453264833207,0.0738747380548001
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37593,0.0532785745314818,0.0397966859015325,-0.024722929835522,0.131280078898486,0.18066800412749
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37593,0.0124116634086715,0.0192038221267186,-0.0252278279596969,0.0500511547770399,0.518088026458908
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37593,0.0173276731533986,0.0121719088707023,-0.00652926823317783,0.0411846145399751,0.154591113458079
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51568,0.015152909306498,0.022558500532189,-0.0290617517365925,0.0593675703495885,0.501770013162464
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51568,0.015152909306498,0.022558500532189,-0.0290617517365925,0.0593675703495885,0.501770013162464
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51568,-0.00516948792519636,0.0165718383228522,-0.0376502910379867,0.027311315187594,0.755085320095674
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51568,-0.0249895903968404,0.0259025254247392,-0.0757585402293292,0.0257793594356484,0.334675969927177
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51568,-0.0205260065586594,0.0632011186435212,-0.144400199099961,0.103348185982642,0.745355456417623
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51568,0.0352351737439934,0.0442489852034873,-0.0514928372548417,0.121963184742828,0.425868357959163
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51568,0.0110266756116536,0.067075921582673,-0.120442130690386,0.142495481913693,0.869424573246986
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51487,0.00353458862700869,0.0127191429607207,-0.0213949315760038,0.0284641088300212,0.781094897245802
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51487,0.00356565278939445,0.0218123103880718,-0.0391864755712262,0.0463177811500151,0.870149789418976
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51487,0.00552765143686735,0.0106856964455478,-0.0154163135964064,0.0264716164701411,0.604954771102031
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51487,0.0315605961695087,0.0200766620868842,-0.00778966152078438,0.0709108538598017,0.115961039708013
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51487,0.0272176458275676,0.0173951405082497,-0.00687682956860181,0.0613121212237371,0.117671876723032
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51487,0.0472019945685695,0.0142014876011407,0.0193670788703338,0.0750369102668052,0.000889356977626126
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29961,0.0157570256058332,0.0373444261569361,-0.0574380496617616,0.088952100873428,0.673085273643906
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29961,-0.039434381454933,0.0321916807515734,-0.102530075728017,0.0236613128181508,0.220627515344397
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29961,0.0473559925806584,0.0405951002052279,-0.0322104038215882,0.126922388982905,0.243439946547757
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29961,0.0310017141991652,0.0333216589224567,-0.0343087372888499,0.0963121656871803,0.352212591832693
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51443,0.0872686638714863,0.0352860104286305,0.0181080834313706,0.156429244311602,0.013397636861892
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51443,0.0201581604893993,0.0507743660942032,-0.079359597055239,0.119675918034038,0.691359826365142
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51443,0.442726314790274,0.104753083745512,0.23741027064907,0.648042358931478,2.38244135300668e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51443,0.13987214597309,0.0907398489610555,-0.0379779579905789,0.317722249936759,0.123215542644478
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51443,0.0173600669714459,0.0328917742398196,-0.0471078105386004,0.0818279444814922,0.597646865580565
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51443,0.0287485924277513,0.0413827578312566,-0.0523616129215115,0.109858797777014,0.487249322431654
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51443,0.0140405534847526,0.0170882024368876,-0.0194523232915471,0.0475334302610524,0.411282160942522
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33395,0.0766850848964036,0.0327899192483213,0.0124168431696938,0.140953326623113,0.0193726190600533
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33395,0.0725026670278897,0.0363762888461181,0.00120514088949833,0.143800193166281,0.0462756792888587
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33395,0.0632930171985071,0.0472432684549994,-0.0293037889732918,0.155889823370306,0.18036649271217
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33395,0.0153955253815722,0.0139338737952222,-0.0119148672570633,0.0427059180202078,0.269231168211553
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35526,0.0215013874689459,0.015597231688598,-0.00906918664070606,0.0520719615785979,0.168063462326914
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35526,-0.0409861863309582,0.0126372723270831,-0.0657552400920411,-0.0162171325698753,0.00118495217835502
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35526,0.0091754240851313,0.0124963550755467,-0.0153174318629402,0.0336682800332028,0.46281234310959
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35527,0.0472429121593935,0.0305051223145123,-0.0125471275770507,0.107032951895838,0.121483900446515
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35527,0.0484641200520597,0.0198803122972578,0.00949870794943454,0.0874295321546849,0.0147919908200485
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35527,-0.0235638744517791,0.0249382036814675,-0.0724427536674554,0.0253150047638973,0.344734293892262
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51487,-0.0467094328699167,0.0293130790683585,-0.104163067843899,0.0107442021040659,0.111066838883586
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51487,-0.00675388450189143,0.0193152770048747,-0.0446118274314459,0.031104058427663,0.726592471298576
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51487,0.0183464275391346,0.0587550865106216,-0.0968135420216837,0.133506397099953,0.754850929340524
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51487,-0.0333460323733744,0.0218910363044572,-0.0762524635301104,0.00956039878336168,0.127701775577101
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51487,-0.0221188697909746,0.0238435848009798,-0.068852296000895,0.0246145564189458,0.353589240574414
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51487,0.0731353598761339,0.026462234048435,0.0212693811412013,0.125001338611067,0.00571767499389675
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51487,0.0231478066163631,0.00853866302454449,0.00641202708825593,0.0398835861444703,0.00671341322621647
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28022,0.0335977844956003,0.0297064585788369,-0.0246268743189201,0.0918224433101207,0.258123376442305
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28022,0.0728239326812328,0.0380743240814873,-0.00180174251848242,0.147449607880948,0.0558578133488268
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28022,-0.0367540707625679,0.0277127245801204,-0.0910710109396039,0.0175628694144681,0.184828841657022
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28022,0.00804945153480884,0.0229102768881802,-0.0368546911660244,0.0529535942356421,0.725346004078793
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51619,-0.0124180365682891,0.00914880233041706,-0.0303496891359066,0.0055136159993283,0.174684196167067
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51619,-0.00370210716884133,0.0268383297842706,-0.0563052335460117,0.0489010192083291,0.890288014331392
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51619,0.00135361146229221,0.00921924713415931,-0.01671611292066,0.0194233358452445,0.883271602747755
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51619,-0.000161800679693877,0.0089680560898308,-0.0177391906157622,0.0174155892563745,0.985605565279886
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51619,0.0235591721493818,0.0129827732914258,-0.00188706350181272,0.0490054078005763,0.0695887083368628
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51619,0.0320822987404964,0.0133591299978716,0.00589840394466811,0.0582661935363247,0.0163333784724381
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51619,0.0146051191595613,0.00987275746445073,-0.00474548547076212,0.0339557237898847,0.139062055996726
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51619,0.0948590465130546,0.028039222191278,0.0399021710181498,0.14981592200796,0.000717756900072852
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42639,-0.0411562763669001,0.00973173077616322,-0.06023046868818,-0.0220820840456202,2.35758774711372e-05
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42639,0.00259029004078981,0.0102183695474677,-0.017437714272247,0.0226182943538266,0.799889675082376
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42639,0.0153974894257065,0.012240655714693,-0.00859419577509189,0.0393891746265049,0.208444492348726
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42640,0.00187278478579476,0.0167985901431996,-0.0310524518948765,0.034798021466466,0.91123323605765
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42640,-0.00797913481013253,0.0107969036041481,-0.0291410658742628,0.0131827962539977,0.459903689310824
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51387,-0.0100344268276845,0.0101233703283546,-0.0298762326712594,0.00980737901589054,0.321589787705548
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51387,-0.015634476248191,0.00794357794448624,-0.031203889019384,-6.50634769979539e-05,0.0490561200335498
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51387,-0.00947045977702408,0.00948337611211926,-0.0280578769567778,0.00911695740272967,0.317978862043535
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51387,-0.0106935975121142,0.0146893251191849,-0.0394846747457167,0.0180974797214882,0.466629412206184
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51402,-0.0279861078806541,0.00871301987298554,-0.0450636268317058,-0.0109085889296025,0.00131971714419014
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51402,-0.0447016694038347,0.0119549116906626,-0.0681332963175335,-0.021270042490136,0.00018498883946142
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51487,-0.0307770506944156,0.00920488883477016,-0.0488186328105651,-0.0127354685782661,0.000828222391512117
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51487,-0.0235017812602907,0.0113341647941762,-0.0457167442568761,-0.00128681826370527,0.0381318119216226
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51487,0.00521526441085045,0.016959470653302,-0.0280252980696214,0.0384558268913223,0.758454946351324
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51487,-0.0610462463672035,0.0198160491347357,-0.0998857026712856,-0.0222067900631215,0.00206754478128869
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51487,-0.0249238327466878,0.0195493645864184,-0.0632405873360679,0.0133929218426922,0.202349062481188
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51487,-0.0692754837501718,0.0278155155479176,-0.12379389422409,-0.0147570732762533,0.0127609608105655
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39610,-0.0107669855709783,0.00551484552834057,-0.0215760828065258,4.21116645691836e-05,0.0509127020576393
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X864.Number of days or week walked 10+ minutes,51110,-0.0136518702439912,0.0170049238815443,-0.0469815210518181,0.0196777805638357,0.422086557204116
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X874.Duration of walks,47530,0.00179987461313817,0.004151913372289,-0.00633787559654827,0.00993762482282461,0.664651988760722
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50395,-0.0250731787179432,0.0164821272446956,-0.0573781481175465,0.00723179068166018,0.128212947516961
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X894.Duration of moderate activity,44384,-0.000484938179616682,0.0197324909332732,-0.0391606204088321,0.0381907440495988,0.980393705554449
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X90087.No-wear time bias adjusted average acceleration,30207,-0.00260071665035946,0.00848087790905385,-0.019223237352105,0.0140218040513861,0.759114874485523
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50400,-0.0712829773494349,0.0169684850310418,-0.104541208010277,-0.0380247466885929,2.66719094583442e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X914.Duration of vigorous activity,39532,-0.00331275382446507,0.00527720720189784,-0.0136560799401848,0.0070305722912547,0.530178485186592
